<SEC-DOCUMENT>0001140361-25-039436.txt : 20251027
<SEC-HEADER>0001140361-25-039436.hdr.sgml : 20251027
<ACCEPTANCE-DATETIME>20251027145348
ACCESSION NUMBER:		0001140361-25-039436
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251027
DATE AS OF CHANGE:		20251027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251419395

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20057767_424b2.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc9ddb1dfc1d8408bbd79f3a471f44f96" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify;"><img width="57" height="47" src="image0.jpg"></div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Filed Pursuant to Rule 424(b)(2)</div>
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Registration Statement No. 333-283969</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="3" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="background-color: #000000; vertical-align: top; width: 50%;">&#160;</td>
            <td style="background-color: #000000; vertical-align: top; width: 50%;"><br>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-size: 8.5pt;">Pricing Supplement dated October 24, 2025 to the</div>
      <div style="text-align: justify; font-size: 8.5pt;">Product Supplement MLN-EI-1 dated February 26, 2025,</div>
      <div style="text-align: justify; font-size: 8.5pt;">Underlier Supplement dated February 26, 2025 and</div>
      <div style="text-align: justify; font-size: 8.5pt;">Prospectus dated February 26, 2025</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z6935ea27adf24413a1585f0b8d319b44" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="border-bottom: 4px solid #00B050; border-left: 4px solid #00B050; border-right: 4px solid #00B050; border-top: 4px solid #00B050; vertical-align: top; width: 99.88%;">
              <div style="text-align: center; color: rgb(0, 176, 80); font-size: 16pt;">The Toronto-Dominion Bank</div>
              <div style="text-align: center; font-size: 10pt;">$1,085,000</div>
              <div style="text-align: center; font-size: 10pt;">Autocallable Contingent Interest Barrier Notes Linked to the Least Performing of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, the Russell </div>
              <div style="text-align: center; font-size: 10pt;">2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index<font style="font-size: 8pt;">&#160;</font>Due October 27, 2028</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; font-size: 7.5pt;">The Toronto-Dominion Bank (&#8220;TD&#8221; or &#8220;we&#8221;) has offered the Autocallable Contingent Interest Barrier Notes (the &#8220;Notes&#8221;) linked to the least performing of the
        Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index<font style="font-size: 8pt;">&#160;</font>(each, a &#8220;Reference Asset&#8221; and together, the &#8220;Reference Assets&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 7.5pt;">The Notes will pay a Contingent Interest Payment on a Contingent Interest Payment Date (including the Maturity Date) at a per annum rate of
        approximately 9.50%<font style="font-size: 8pt;">&#160;</font>(the &#8220;Contingent Interest Rate&#8221;<font style="font-size: 8pt;">)</font> only if, on the related Contingent Interest Observation Date, the Closing Value
        of each Reference Asset is greater than or equal to its Contingent Interest Barrier Value, which is equal to 70.00% of its Initial Value. If, however, the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on a
        Contingent Interest Observation Date, no Contingent Interest Payment will accrue or be payable on the related Contingent Interest Payment Date. The Notes will be automatically called if, on any Call Observation Date, the Closing Value of each
        Reference Asset is greater than or equal to its Call Threshold Value, which is equal to 100.00% of its Initial Value. If the Notes are automatically called, on the first following Contingent Interest Payment Date (the &#8220;Call Payment Date&#8221;), we will
        pay a cash payment per Note equal to the Principal Amount, plus any Contingent Interest Payment otherwise due. No further amounts will be owed under the Notes. If the Notes are not automatically called, the amount we pay at maturity, in addition to
        any Contingent Interest Payment otherwise due, if anything, will depend on the Closing Value of each Reference Asset on its Final Valuation Date (each, its &#8220;Final Value&#8221;) relative to its Barrier Value, which is equal to 70.00% of its Initial Value,
        calculated as follows:</div>
      <table cellspacing="0" cellpadding="0" id="zc62475b58218473eb5d8fd9d32213ffb" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 3pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 7.5pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 7.5pt;">If the Final Value of each Reference Asset is greater than or equal to its Barrier Value<font style="font-size: 8pt;">:</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 3pt; font-size: 7.5pt;">the Principal Amount of $1,000</div>
      <table cellspacing="0" cellpadding="0" id="za647314fbb844f2789e6ac864b198ae2" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 3pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 7.5pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 7.5pt;">If the Final Value of any Reference Asset is less than its Barrier Value<font style="font-size: 8pt;">:</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 3pt; font-size: 7.5pt;">the sum of (1) $1,000 plus (2) the product of (i) $1,000 times (ii) the Least Performing Percentage Change</div>
      <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;"><font style="font-weight: bold; font-style: italic;">If the Notes are not automatically called and the Final Value of
          any Reference Asset is less than its Barrier Value, investors will suffer a percentage loss on their initial investment that is equal to the percentage decline of the Reference Asset with the lowest Percentage Change from its Initial Value to its
          Final Value (the &#8220;Least Performing Reference Asset&#8221;). Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose
          the entire Principal Amount.</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">Any payments on the Notes are subject to our credit risk.</font></div>
      <table cellspacing="0" cellpadding="0" border="0" id="z7eb41c9a3b2d4aa2bc8ac2a2a72d3314" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%;">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); vertical-align: top; width: 98%;">
              <div style="font-size: 8pt; font-weight: bold; text-align: justify;">The Notes do not guarantee the payment of any Contingent Interest Payments or the return of the Principal Amount. Investors are exposed to the market
                risk of each Reference Asset on each Contingent Interest Observation Date (including the Final Valuation Date) and any decline in the value of one Reference Asset will not be offset or mitigated by a lesser decline or potential increase in
                the value of any other Reference Asset. If the Final Value of any Reference Asset is less than its Barrier Value, investors may lose up to their entire investment in the Notes. Any payments on the Notes are subject to our credit risk.</div>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); vertical-align: top; width: 1%;">&#160;</td>
          </tr>

      </table>
      <div style="margin: 2pt 0px; font-size: 7.5pt; text-align: justify;">The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada Deposit Insurance
        Corporation, the U.S. Federal Deposit Insurance Corporation or any other governmental agency or instrumentality of Canada or the United States. The Notes will not be listed or displayed on any securities exchange or electronic communications
        network.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 7.5pt;"><font style="font-weight: bold;">The Notes have complex features and investing in the Notes involves a number of risks.
          See &#8220;Additional Risk Factors&#8221; beginning on page P-7 of this pricing supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; beginning on page PS-7 of the product supplement MLN-EI-1 dated February 26, 2025 (the &#8220;product supplement&#8221;)</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold;">and &#8220;Risk Factors&#8221; on page 1 of the prospectus dated February 26, 2025 (the &#8220;prospectus&#8221;).</font></div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 7.5pt; font-weight: bold;">Neither the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Notes
        or determined that this pricing supplement, the product supplement, the underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 7.5pt;">We will deliver the Notes in book-entry only form through the facilities of The Depository Trust Company on the Issue Date against payment in immediately
        available funds.</div>
      <div style="text-align: justify; margin-bottom: 2pt; font-size: 7.5pt;">The estimated value of your Notes at the time the terms of your Notes were set on the Pricing Date was $984.40 per Note, as discussed further under
        &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; beginning on page P-9 and &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on page P-22 of this pricing supplement. The estimated value is less than the
        public offering price of the Notes.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="ze6f3c2e916d64cba9ca61cd46120df0c" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 17.87%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">&#160;</td>
            <td style="width: 25.96%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Public Offering Price</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="width: 30.2%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 17.87%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;">Per Note</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$1,000.00</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$2.50</div>
            </td>
            <td style="width: 30.2%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$997.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 17.87%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7.5pt;">Total</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$1,085,000.00</div>
            </td>
            <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$2,712.50</div>
            </td>
            <td style="width: 30.2%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="margin-bottom: 3pt; font-size: 7.5pt;">$1,082,287.50</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="zb295741890734c76a2de0ed9631870c9" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">TD Securities (USA) LLC (&#8220;TDS&#8221;) will receive a commission of $2.50 (0.25%) per Note and will use all of that commission to allow selling concessions
                  to other dealers in connection with the distribution of the Notes. Such other dealers may resell the Notes to other securities dealers at the Principal Amount less a concession not in excess of $2.50 per Note. TD will also periodically
                  pay another unaffiliated dealer a marketing fee of $7.50 per Note with respect to all of the Notes in connection with its marketing efforts. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of
                  the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes. See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; herein.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 7pt; text-align: justify;">The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additional Notes after the date of
        this pricing supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the Notes will depend in part on the
        public offering price you pay for such Notes.</div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">1</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z6bdc47eae6e3465586a738a0a9f88126" style="border-collapse: collapse; margin: 0px 0px 9pt; width: 100%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

          <tr>
            <td style="width: 44.64%; vertical-align: middle;">&#160;</td>
            <td style="width: 55.36%; vertical-align: middle;">
              <div style="text-align: right; font-size: 8pt;"><font style="font-weight: bold;">Autocallable Contingent Interest Barrier Notes Linked to the Least Performing </font></div>
              <div style="text-align: right; font-size: 8pt;"><font style="font-weight: bold;">of the Nasdaq-100 Index</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;">, the Russell 2000</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;"> Index and the S&amp;P 500</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;"> Index</font></div>
              <div style="text-align: right; font-size: 8pt; font-weight: bold;">Due October 27, 2028</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="background-color: #000000; vertical-align: top; width: 44.64%;">&#160;</td>
            <td style="background-color: #000000; vertical-align: top; width: 55.36%;">&#160;</td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Summary</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The information in this &#8220;Summary&#8221; section is qualified by the more detailed information set forth in this pricing supplement, the product supplement, the
        underlier supplement and the prospectus.</div>
      <table cellspacing="0" cellpadding="4" border="0" id="z6ced791c40bd4a30884a6df0a9ea76f9" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issuer:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Senior Debt Securities, Series H</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Type of Note:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Autocallable Contingent Interest Barrier Notes</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Term:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Approximately 3 years, subject to an automatic call</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Reference Assets:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">The Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (Bloomberg ticker: NDX, &#8220;NDX&#8221;), the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (Bloomberg ticker: RTY, &#8220;RTY&#8221;) and the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index
                (Bloomberg ticker: SPX, &#8220;SPX&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">89115HYK7 / US89115HYK75</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Agent:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">TDS</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Currency:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">U.S. Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Minimum Investment:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">$1,000 and minimum denominations of $1,000 in excess thereof</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Principal Amount:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">$1,000 per Note</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Pricing Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">October 24, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">October 29, 2025, which is the third DTC settlement day following the Pricing Date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended
                (the &#8220;Exchange Act&#8221;), trades in the secondary market generally are required to settle in one DTC settlement day (&#8220;T+1&#8221;), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in the
                secondary market on any date prior to one DTC settlement day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in three DTC settlement days (&#8220;T+3&#8221;), to specify alternative settlement
                arrangements to prevent a failed settlement of the secondary market trade.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Final Valuation Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">The final Contingent Interest Observation Date, as specified below under &#8220;Contingent Interest Observation Dates&#8221;.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Maturity Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">October 27, 2028, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Feature:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">If the Closing Value of each Reference Asset on any Call Observation Date is greater than or equal to its Call Threshold Value, we will automatically
                call the Notes and, on the related Call Payment Date, we will pay you a cash payment per Note equal to the Principal Amount, plus any Contingent Interest Payment otherwise due. No further amounts will be owed to you under the Notes.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">2</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" id="z84faffb458a8410c8d28158daa8c4ca6" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Call Threshold Value:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to NDX: 25,358.16<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to RTY: 2,513.470<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to SPX: 6,791.69<font style="font-size: 8pt;">&#160;</font>(100.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Call Threshold Value for each Reference Asset is determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Observation Dates:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Quarterly, on the 24th calendar day of each January, April, July and October, commencing on October 24, 2026 and ending on July 24, 2028, subject to
                postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Payment Date:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">If the Notes are subject to an automatic call, the Call Payment Date will be the Contingent Interest Payment Date immediately following the relevant
                Call Observation Date, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Contingent Interest Payment:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">If the Closing Value of each Reference Asset is greater than or equal to its Contingent Interest Barrier Value on any Contingent Interest Observation
                Date, a Contingent Interest Payment will be paid to you on the corresponding Contingent Interest Payment Date, in an amount equal to:</div>
              <div style="text-align: center; margin-bottom: 6pt;">Principal Amount &#215; Contingent Interest Rate &#215; <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>/<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">12</sub></div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on any Contingent Interest Observation Date, you will
                receive no Contingent Interest Payment on the corresponding Contingent Interest Payment Date.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">All amounts used in or resulting from any calculation relating to a Contingent Interest Payment will be rounded upward or downward, as appropriate, to
                the nearest tenth of a cent.</div>
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Contingent Interest Payments on the Notes are not guaranteed. You will not receive a Contingent Interest Payment on a Contingent
                Interest Payment Date if the Closing Value of any Reference Asset on the related Contingent Interest Observation Date is less than its Contingent Interest Barrier Value.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Contingent Interest Rate:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">Approximately 9.50% per annum</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Contingent Interest Barrier </div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Value:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to NDX: 17,750.712<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to RTY: 1,759.429<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="margin-bottom: 6pt;">With respect to SPX: 4,754.183<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Contingent Interest Barrier Value for each Reference Asset is determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Contingent Interest </div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Observation Dates:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Monthly, on the 24th calendar day of each month, commencing on November 24, 2025 and ending on October 24, 2028<font style="font-size: 8pt;">&#160;</font>(the &#8220;Final Valuation Date&#8221;), subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold; text-align: justify;">Contingent Interest Payment </div>
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Dates:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to each Contingent Interest Observation Date, the third Business Day following the relevant Contingent Interest Observation Date, with the
                exception of the final Contingent Interest Payment Date, which will be the Maturity Date, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">3</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" id="z692cc41e53434ff19f691b539195b30a" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Payment at Maturity:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">If the Notes are not automatically called, on the Maturity Date, in addition to any Contingent Interest Payment otherwise due, we will pay a cash
                payment, if anything,<font style="font-size: 8pt;">&#160;</font>per Note equal to:</div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Final Value of each Reference Asset is greater than or equal to its Barrier Value<font style="font-size: 8pt;">:</font></div>
              <div style="text-align: center; margin-bottom: 6pt;">Principal Amount of $1,000.</div>
              <div style="text-align: justify; margin-bottom: 6pt;">If the Final Value of any Reference Asset is less than its Barrier Value<font style="font-size: 8pt;">:</font></div>
              <div style="text-align: center; margin-bottom: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change).</div>
              <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-weight: bold; font-style: italic;">If the Notes are not automatically called and the Final Value
                  of any Reference Asset is less than its Barrier Value, investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of the Principal
                  Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">Any payments on the Notes are subject to our credit risk.</font></div>
              <div>All amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward, as appropriate, to the nearest cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Percentage Change:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset, the Percentage Change is the quotient, expressed as a percentage, of the following formula:</div>
              <div style="text-align: center;"><u>Final Value &#8211; Initial Value</u></div>
              <div style="text-align: center; margin-bottom: 6pt;">Initial Value</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Initial Value:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to NDX: 25,358.16</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to RTY: 2,513.470</div>
              <div style="text-align: justify; margin-bottom: 6pt;">With respect to SPX: 6,791.69</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Initial Value of each Reference Asset equals its Closing Value on the Pricing Date, as determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Closing Value:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">For each Reference Asset (or any "successor index" thereto, as defined in the product supplement) on any Trading Day, the Closing Value will be its
                closing value published by its sponsor (its "Index Sponsor") as displayed on the relevant Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;) page or any successor page or service.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Final Value:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">For each Reference Asset, the Closing Value of such Reference Asset on its Final Valuation Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt; font-weight: bold;">Barrier Value:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-bottom: 6pt;">With respect to NDX: 17,750.712<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value).</div>
              <div style="margin-bottom: 6pt;">With respect to RTY: 1,759.429<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value).</div>
              <div style="margin-bottom: 6pt;">With respect to SPX: 4,754.183<font style="font-size: 8pt;">&#160;</font>(70.00% of its Initial Value).</div>
              <div style="text-align: justify; margin-bottom: 6pt;">The Barrier Value for each Reference Asset is determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Least Performing Reference </div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Asset:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Reference Asset with the lowest Percentage Change as compared to the Percentage Change of any other Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold;">Least Performing Percentage </div>
              <div style="margin-bottom: 6pt; font-weight: bold;">Change:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Percentage Change of the Least Performing Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Monitoring Period:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Final Valuation Date Monitoring</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading Day:</div>
              <div>&#160;</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">A day on which the NYSE and the Nasdaq Stock Market, or their successors, are scheduled to be open for trading, as determined by the Calculation Agent.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">4</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="4" border="0" id="z25573009cb54418e9d30e15b2f738e1b" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Business Day:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized
                or required by law to close in New York City.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">U.S. Tax Treatment:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">By purchasing the Notes, you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the
                contrary, to treat the Notes, for U.S. federal income tax purposes, as prepaid derivative contracts with respect to the Reference Assets. Pursuant to this approach, it is likely that any Contingent Interest Payment that you receive should
                be included in ordinary income at the time you receive the payment or when it accrues, depending on your regular method of accounting for U.S. federal income tax purposes. Based on certain factual representations received from us, our
                special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be reasonable to treat the Notes in the manner described above. However, because there is no authority that specifically addresses
                the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of
                your income from the Notes could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement. <font style="font-weight: bold;">An investment in the Notes is not appropriate for non-U.S. holders and we will not attempt to ascertain the tax consequences to non-U.S. holders of the purchase, ownership or disposition of the
                  Notes.</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Tax Treatment:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of
                Canadian Tax Consequences&#8221;, which applies to the Notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian
                Tax Act (as defined in the prospectus).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Record Date:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Business Day preceding the relevant Contingent Interest Payment Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation Agent:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Listing:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Bail-in:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes are not bail-inable debt securities (as defined in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Change in Law Event:</div>
            </td>
            <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Not applicable, notwithstanding anything to the contrary in the product supplement.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">5</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Terms of Your Notes</div>
      <div style="text-align: justify; margin-bottom: 6pt;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement <font style="font-size: 8.5pt;">MLN-EI-1 (the &#8220;product supplement&#8221;)</font><font style="font-size: 8pt;">&#160;</font>and the underlier supplement (the &#8220;underlier supplement&#8221;), relating to our Senior Debt Securities, Series H, of which these Notes are a
        part. Capitalized terms used but not defined in this pricing supplement will have the meanings given to them in the product supplement. In the event of any conflict the following hierarchy will govern: first, this pricing supplement; second, the
        product supplement; third, the underlier supplement; and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the terms described in the product supplement in several
          important ways. You should read this pricing supplement carefully.</font></div>
      <div style="text-align: justify; margin-bottom: 6pt;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements
        as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully
        consider, among other things, the matters set forth in &#8220;Additional Risk Factors&#8221; herein, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with
        conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the SEC website at www.sec.gov as follows (or if that address
        has changed, by reviewing our filings for the relevant date on the SEC website):</div>
      <table cellspacing="0" cellpadding="0" id="zc0ff7529515d4fbab88ac84fd188d05b" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Prospectus dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
      <table cellspacing="0" cellpadding="0" id="z9c5102bfd8f441f18c19084ca8dcdb0f" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Underlier Supplement dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm</a></div>
      <table cellspacing="0" cellpadding="0" id="z8983a799f85847a388fe07c0be7b9705" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Product Supplement MLN-EI-1 dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm</a></div>
      <div style="text-align: justify; margin-bottom: 6pt;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The
        Toronto-Dominion Bank and its subsidiaries.</div>
      <div style="text-align: justify;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will
        notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">6</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the
        terms of the Notes. For additional information as to these and other risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Investors should consult their investment, legal, tax, accounting and other advisors as to the risks entailed by an investment in the Notes and the suitability
        of the Notes in light of their particular circumstances.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
      <div style="margin-bottom: 6pt; font-weight: bold;">Your Investment in the Notes May Result in a Loss.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes. Specifically, if the Notes are
        not automatically called and the Final Value of any Reference Asset is less than its Barrier Value, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than
        its Initial Value, and may lose the entire Principal Amount.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">You Will Not Receive the Contingent Interest Payment With Respect to a Contingent Interest Observation Date if the Closing Value of Any
        Reference Asset on Such Contingent Interest Observation Date Is Less Than Its Contingent Interest Barrier Value.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">You will not receive a Contingent Interest Payment on a Contingent Interest Payment Date if the Closing Value of any Reference Asset on the related Contingent
        Interest Observation Date is less than its Contingent Interest Barrier Value. If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date over the term of the Notes,
        you will not receive any Contingent Interest Payments and, therefore, you will not receive a positive return on your Notes. Generally, this non-payment of any Contingent Interest Payment will coincide with a greater risk of principal loss on your
        Notes at maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Potential Positive Return on the Notes Is Limited to the Contingent Interest Payments Paid on the Notes, if Any, Regardless of Any
        Appreciation of Any Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The potential positive return on the Notes is limited to any Contingent Interest Payments paid, meaning any positive return on the Notes will be composed solely
        of the sum of any Contingent Interest Payments paid over the term of the Notes. Therefore, if the appreciation of any Reference Asset exceeds the sum of any Contingent Interest Payments actually paid on the Notes, the return on the Notes will be
        less than the return on a hypothetical direct investment in such Reference Asset, in a security directly linked to the positive performance of such Reference Asset or a hypothetical investment in the stocks and other assets comprising such
        Reference Asset (its &#8220;Reference Asset Constituents&#8221;).</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Your Return May Be Less Than the Return on a Conventional Debt Security of Comparable Maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The return that you will receive on your Notes, which could be negative, may be less than the return you could earn on other investments. The Notes do not
        provide for fixed interest payments and you may not receive any Contingent Interest Payments over the term of the Notes. Even if you do receive one or more Contingent Interest Payments and your return on the Notes is positive, your return may be
        less than the return you would earn if you bought a conventional, interest-bearing senior debt security of TD of comparable maturity. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect
        the time value of money.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes May Be Automatically Called Prior to the Maturity Date and Are Subject to Reinvestment Risk.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">If your Notes are automatically called, no further payments will be owed to you under the Notes after the applicable Call Payment Date. Therefore, because the
        Notes could be called as early as the first potential Call Payment Date, the holding period could be limited. There is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes at a comparable return for a similar
        level of risk in the event the Notes are automatically called prior to the Maturity Date. Furthermore, to the extent you are able to reinvest such proceeds in an investment with a comparable return for a similar level of risk, you may incur
        transaction costs such as dealer discounts and hedging costs built into the price of the new notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Amounts Payable on the Notes Are Not Linked to the Value of the Least Performing Reference Asset at Any Time Other Than on the Contingent
        Interest Observation Dates (Including the Final Valuation Date) And Call Observation Dates.</div>
      <div style="text-align: justify;">Any payments on the Notes will be based on the Closing Value of the Least Performing Reference Asset only on the Contingent Interest Observation Dates (including the Final
        Valuation Date) and Call Observation Dates. Even if the value of the Least Performing Reference Asset appreciates prior to a Contingent Interest Observation Date but then drops on that day to a Closing Value that is less than its Contingent
        Interest Barrier Value, you will not receive any Contingent Interest Payment with respect to such Contingent Interest Observation Date. Similarly, the Payment at Maturity may be significantly less than it would have been had the Notes been linked
        to the Closing Value of the Least Performing Reference Asset on a date other than the Final Valuation Date, and may be zero. Although the actual values of the Reference Assets at other times during the term of the Notes may be higher than the
        values on one or more Contingent Interest Observation Dates (including the Final Valuation Date) or Call Observation Dates, any Contingent Interest Payments on the Notes and the Payment at Maturity will be based solely on the Closing Value of the
        Least Performing Reference Asset on the applicable Contingent Interest Observation Date (including the Final Valuation Date) and Call Observation Dates.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">7</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Contingent Interest Rate Will Reflect, in Part, the Volatility of Each Reference Asset and May Not Be Sufficient to Compensate You for
        the Risk of Loss at Maturity.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Generally, the higher a Reference Asset&#8217;s volatility, the more likely it is that the Closing Value of that Reference Asset could be less than its Call Threshold
        Value or its Contingent Interest Barrier Value on a Call Observation Date or Contingent Interest Observation Date or its Barrier Value on its Final Valuation Date. Volatility means the magnitude and frequency of changes in the value of a Reference
        Asset. This greater risk will generally be reflected in a higher Contingent Interest Rate for the Notes than the interest rate payable on our conventional debt securities with a comparable term. However, while the Contingent Interest Rate is set on
        the Pricing Date, a Reference Asset&#8217;s volatility can change significantly over the term of the Notes, and may increase. The value of any Reference Asset could fall sharply on the Contingent Interest Observation Dates, resulting in few or no
        Contingent Interest Payments or on the Final Valuation Date, resulting in a loss of a significant portion or all of the Principal Amount.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Assets</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Market Risks Associated With Each Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The value of each Reference Asset can rise or fall sharply due to factors specific to such Reference Asset, its Reference Asset Constituents and their issuers
        (the &#8220;Reference Asset Constituent Issuers&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors, such
        as general stock market volatility and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own investigation into the Reference Assets, the Reference Asset Constituents and the Reference
        Asset Constituent Issuers for your Notes. For additional information, see &#8220;Information Regarding the Reference Assets&#8221; in this pricing supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Investors Are Exposed to the Market Risk of Each Reference Asset on Each Contingent Interest Observation Date (Including the Final Valuation
        Date).</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Your return on the Notes is not linked to a basket consisting of the Reference Assets. Rather, it will be contingent upon the performance of each Reference
        Asset. Unlike an instrument with a return linked to a basket of indices, common stocks or other underlying securities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks
        related to each Reference Asset on each Contingent Interest Observation Date (including the Final Valuation Date). Poor performance by any Reference Asset over the term of the Notes will negatively affect your return and will not be offset or
        mitigated by a positive performance by any other Reference Asset. For instance, if the Final Value of any Reference Asset is less than its Barrier Value on its Final Valuation Date, you will receive a negative return equal to the Least Performing
        Percentage Change,<font style="font-size: 8pt;">&#160;</font>even if the Percentage Change of another Reference Asset is positive or has not declined as much. Accordingly, your investment is subject to the market risk of each
        Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Because the Notes Are Linked to the Least Performing Reference Asset, You Are Exposed to a Greater Risk of No Contingent Interest Payments
        and Losing a Significant Portion or All of Your Initial Investment at Maturity Than if the Notes Were Linked to a Single Reference Asset or Fewer Reference Assets.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The risk that you will not receive any Contingent Interest Payments and lose a significant portion or all of your initial investment in the Notes is greater if
        you invest in the Notes than the risk of investing in substantially similar securities that are linked to the performance of only one Reference Asset or fewer Reference Assets. With more Reference Assets, it is more likely that the Closing Value of
        any Reference Asset will be less than its Contingent Interest Barrier Value on any Contingent Interest Observation Date (including the Final Valuation Date) and that the Final Value of any Reference Asset will be less than its Barrier Value on the
        Final Valuation Date than if the Notes were linked to a single Reference Asset or fewer Reference Assets.</div>
      <div style="text-align: justify;">In addition, the lower the correlation is between the performance of a pair of Reference Assets, the more likely it is that one of the Reference Assets will decline in value to a
        Closing Value or Final Value, as applicable, that is less than its Contingent Interest Barrier Value or Barrier Value on any Call Observation Date or Contingent Interest Observation Date (including the Final Valuation Date). Although the
        correlation of the Reference Assets&#8217; performance may change over the term of the Notes, the economic terms of the Notes, including the Contingent Interest Rate, Contingent Interest Barrier Value and Barrier Value are determined, in part, based on
        the correlation of the Reference Assets&#8217; performance calculated using our internal models at the time when the terms of the Notes are finalized. All things being equal, a higher Contingent Interest Rate and lower Contingent Interest Barrier Values
        and Barrier Values are generally associated with lower correlation of the Reference Assets. Therefore, if the performance of a pair of Reference Assets is not correlated to each other or is negatively correlated, the risk that you will not receive
        any Contingent Interest Payments or that the Final Value of any Reference Asset is less than its Barrier Value will occur is even greater despite a lower Contingent Interest Barrier Value and Barrier Value, respectively. Therefore, it is more
        likely that you will not receive any Contingent Interest Payments and that you will lose a significant portion or all of your initial investment at maturity.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">8</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">We Have No Affiliation With Any Index Sponsor and Will Not Be Responsible for Any Actions Taken by Any Index Sponsor.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">No index sponsor as specified under &#8220;Information Regarding the Reference Assets&#8221; (an &#8220;Index Sponsor&#8221;) is an affiliate of ours and no such entity will be
        involved in any offering of the Notes in any way. Consequently, we have no control of any actions of any Index Sponsor, including any actions of the type that could adversely affect the value of the applicable Reference Asset or any amounts payable
        on the Notes. No Index Sponsor has any obligation of any sort with respect to the Notes. Thus, no Index Sponsor has any obligation to take your interests into consideration for any reason, including in taking any actions that might affect the value
        of the Notes. None of our proceeds from any issuance of the Notes will be delivered to any Index Sponsor, except to the extent that we are required to pay an Index Sponsor licensing fees with respect to the applicable Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Changes that Affect the Reference Assets May Adversely Affect the Market Value of, and Return on, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The policies of each Index Sponsor concerning the calculation of the applicable Reference Asset, additions, deletions or substitutions of the Reference Asset
        Constituents and the manner in which changes affecting those Reference Asset Constituents, such as stock dividends, reorganizations or mergers, may be reflected in the applicable Reference Asset and could adversely affect the market value of, and
        return on, the Notes. The market value of, and return on, the Notes could also be affected if an Index Sponsor changes these policies, for example, by changing the manner in which it calculates the applicable Reference Asset, or if an Index Sponsor
        discontinues or suspends calculation or publication of the applicable Reference Asset. If events such as these occur, the Calculation Agent may select a successor index or take other actions as discussed in the product supplement and,
        notwithstanding these adjustments, the market value of, and return on, the Notes may be adversely affected.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index Reflects Price Return, not Total Return.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The return on the Notes is based on the performance of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, which
        reflects the changes in the market prices of its Reference Asset Constituents. The Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is not a &#8220;total return&#8221; index or strategy, which, in addition to
        reflecting those price returns, would also reflect dividends paid on its Reference Asset Constituents. The return on the Notes will not include such a total return feature or dividend component.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes are Subject to Risks Associated with Small-Capitalization Companies.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Notes are subject to risks associated with small-capitalization companies because the Reference Asset Constituents of the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index are
        considered small-capitalization companies. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore such index may be more volatile than an index in which a
        greater percentage of its constituents are issued by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic developments,
        and the stocks of small-capitalization companies may be thinly traded. In addition, small-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel, making
        them more vulnerable to loss of personnel. Small-capitalization companies are often given less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less
        diverse product lines, smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Less Than the Public Offering Price of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes is less than the public offering price of your Notes. The difference between the public offering price of your Notes and the
        estimated value of the Notes reflects costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes. Because hedging our obligations entails risks and may be influenced by market
        forces beyond our control, this hedging may result in a profit that is more or less than expected, or a loss.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.</div>
      <div style="text-align: justify;">The estimated value of your Notes is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated value of the Notes
        generally represents a discount from the credit spreads for our conventional, fixed-rate debt securities and the borrowing rate we would pay for our conventional, fixed-rate debt securities. This discount is based on, among other things, our view
        of the funding value of the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any hedge
        positions, taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt securities, or the borrowing rate we would pay for our conventional, fixed-rate debt
        securities were to be used, we would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Notes is expected to increase
        the estimated value of the Notes at any time.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">9</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be Different From the
        Pricing Models of Other Financial Institutions.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes is based on our internal pricing models when the terms of the Notes are set, which take into account a number of variables,
        such as our internal funding rate on the Pricing Date, and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different
        from other financial institutions&#8217; pricing models and the methodologies used by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary
        market. As a result, the secondary market price of your Notes may be materially less than the estimated value of the Notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the
        future may change, and any assumptions may prove to be incorrect.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, if Any, and
        Such Secondary Market Prices, if Any, Will Likely Be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of the Notes is not a prediction of the prices at which the Agent, other affiliates of ours or third parties may be willing to purchase the
        Notes from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many
        factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into
        account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the
        Notes, secondary market prices of your Notes will likely be less than the public offering price of your Notes. As a result, the price at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in
        secondary market transactions, if any, will likely be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Temporary Price at Which the Agent May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your
        Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary
        market (if the Agent makes a market in the Notes, which it is not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Issue Date of
        the Notes, as discussed further under &#8220;Additional Information Regarding the Estimated Value of the Notes.&#8221; The price at which the Agent may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your
        Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Underwriting Discount, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than
        the public offering price. The public offering price includes, and any price quoted to you is likely to exclude, any underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our
        obligations under the Notes. In addition, any such price is also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge
        transaction.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or electronic communications
        network. The Agent or another one of our affiliates may make a market for the Notes; however, it is not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide
        significant liquidity or trade at prices advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be
        substantial.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">If you sell your Notes before the Maturity Date, you may have to do so at a substantial discount from the public offering price irrespective of the value of the
        then-current least performing Reference Asset, and as a result, you may suffer substantial losses.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">If the Value of Any Reference Asset Changes, the Market Value of Your Notes May Not Change in the Same Manner.</div>
      <div style="text-align: justify;">Your Notes may trade quite differently from the performance of any of the Reference Assets. Changes in the value of any Reference Asset may not result in a comparable change in the
        market value of your Notes. Even if the Closing Value of each Reference Asset remains greater than or equal to its Barrier Value and Contingent Interest Barrier Value or increases to greater than its Call Threshold Value during the term of the
        Notes, the market value of your Notes may not increase by the same amount and could decline.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">10</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The Calculation Agent will, among other things, determine the amounts payable on the Notes. We will serve as the Calculation Agent and may appoint a different
        Calculation Agent after the Issue Date without notice to you. The Calculation Agent will exercise its judgment when performing its functions and may have a conflict of interest if it needs to make certain decisions. For example, the Calculation
        Agent may have to determine whether a market disruption event affecting a Reference Asset has occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment as to whether the event has
        materially interfered with our ability or the ability of one of our affiliates to unwind our hedge positions. Because this determination by the Calculation Agent may affect the amounts payable on the Notes, the Calculation Agent may have a conflict
        of interest if it needs to make a determination of this kind. For additional information on the Calculation Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Contingent Interest Observation Dates (Including the Final Valuation Date), Call Observation Dates and the Related Payment Dates Are
        Subject to Market Disruption Events and Postponements.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Each Contingent Interest Observation Date (including the Final Valuation Date), Call Observation Date and related payment date (including the Maturity Date) is
        subject to postponement due to the occurrence of one or more market disruption events. For a description of what constitutes a market disruption event as well as the consequences of that market disruption event, see &#8220;General Terms of the Notes &#8212;
        Market Disruption Events&#8221; in the product supplement. A market disruption event for a particular Reference Asset will not constitute a market disruption event for any other Reference Asset.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading and Business Activities by TD or Its Affiliates May Adversely Affect the Market Value Of, and Any Amounts Payable On, the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We, the Agent and/or our other affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments
        with returns linked or related to changes in the value of a Reference Asset or one or more Reference Asset Constituents, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is
        possible that we or one or more of our affiliates could receive substantial returns from these hedging activities while the market value of the Notes declines. We or one or more of our affiliates may also issue or underwrite other securities or
        financial or derivative instruments with returns linked or related to changes in a Reference Asset or one or more Reference Asset Constituents.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and our affiliates will have in our or their
        proprietary accounts, in facilitating transactions, including options and other derivatives transactions, for our or their customers&#8217; accounts and in accounts under our or their management. These trading activities could be adverse to the interests
        of the holders of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="color: rgb(0, 0, 0);">We, the Agent and/or our other affiliates may, </font>at present or in the future,
        engage in business with one or more Reference Asset Constituent Issuers, including making loans to or providing advisory services to those companies. These services could include investment banking and merger and acquisition advisory services.
        These business activities may present a conflict between <font style="color: rgb(0, 0, 0);">our, the Agent&#8217;s and/or our other affiliates&#8217; obligations</font>, and your interests as a holder of the Notes.
        Moreover, we, the Agent and/or our <font style="color: rgb(0, 0, 0);">other </font>affiliates may have published, and in the future expect to publish, research reports with respect to a Reference Asset or one
        or more Reference Asset Constituents. This research is modified from time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding the Notes. Any of these activities by us and/or
        our <font style="color: rgb(0, 0, 0);">other </font>affiliates may affect the value of a Reference Asset and, therefore, the market value of, and any amounts payable on, the Notes.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Although the return on the Notes will be based on the performance of the Least Performing Reference Asset, the payment of any amount due on the Notes is subject
        to TD&#8217;s credit risk. The Notes are TD&#8217;s senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s
        view of TD&#8217;s creditworthiness. Any decrease in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its
        financial obligations as they become due, investors may not receive any amounts due under the terms of the Notes.</div>
      <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
      <div style="text-align: justify;">The U.S. tax treatment of the Notes is uncertain. Please read carefully the section entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement.
        You should consult your tax advisor as to the tax consequences of your investment in the Notes.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">11</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221;
        and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Summary&#8221;. If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal
        income tax purposes or if you acquire the Notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due under the Notes.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">12</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Hypothetical Returns</div>
      <div style="text-align: justify; margin-top: 6pt;">The examples set out below are included for illustration purposes only and are hypothetical examples only; amounts below may have been rounded for ease of
        analysis. The hypothetical Initial Values, Closing Values, Final Values and<font style="font-weight: bold;">&#160;</font>Percentage Changes of the Reference Assets used to illustrate the calculation of whether a
        Contingent Interest Payment is payable on a Contingent Interest Payment Date and the Payment at Maturity are not estimates or forecasts of the actual Initial Value, Closing Value or Final Value of any Reference Asset, or the value of any Reference
        Asset on any Trading Day prior to the Maturity Date. All examples assume, for Reference Asset A, Reference Asset B and Reference Asset C, respectively, Initial Values of 24,500.00, 2,500.00 and 6,500.00, Call Threshold Values of 24,500.00, 2,500.00
        and 6,500.00 (each 100.00% of its Initial Value), Contingent Interest Barrier Values of 17,150.00, 1,750.00 and 4,550.00 (each 70.00% of its Initial Value), Barrier Values of 17,150.00, 1,750.00 and 4,550.00 (each 70.00% of its Initial Value), a
        Contingent Interest Payment of $7.917 per Note (reflecting the Contingent Interest Rate of approximately 9.50% per annum), that a holder purchased Notes with a Principal Amount of $1,000 and that no market disruption event occurs on any Call
        Observation Date or Contingent Interest Observation Date (including the Final Valuation Date). The actual terms of the Notes are set forth elsewhere in this pricing supplement.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Example 1 &#8212; The Closing Value of Each Reference Asset is Greater Than or Equal to its Call Threshold Value on the First Call Observation Date
        and the Notes are Automatically Called.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z0ce9b28f7261476184e0eae8019888e1" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: bottom; width: 1%; padding-bottom: 1px;" colspan="1">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 18%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="vertical-align: top; width: 1%; padding-bottom: 1px;"><br>
            </td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 49%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-top: 3pt;">First through Eleventh Contingent Interest Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to </font>its Call Threshold
                Value and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$87.087 (Aggregate Contingent Interest Payments &#8211; Not Callable)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-top: 3pt;">Twelfth Contingent Interest Observation Date and First Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: 25,725.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: 3,000.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and
                Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: 8,125.00 (<font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value and
                Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 6pt;">$1,000.00 (Principal Amount)</div>
              <div><u>+ $7.917</u> (Contingent Interest Payment)</div>
              <div>$1,007.917 (Total Payment upon Automatic Call)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">&#160;</td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,095.004 (9.5004% total return)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;">Because the Closing Value of each Reference Asset is greater than or equal to its Call Threshold Value (and therefore also greater than its Contingent Interest Barrier Value) on
        the first Call Observation Date (which is approximately 12 months after the Pricing Date), the Notes will be automatically called and, on the corresponding Call Payment Date, we will pay you a cash payment equal to $1,007.917 per Note, reflecting
        the Principal Amount plus the applicable Contingent Interest Payment. When added to the Contingent Interest Payments of $87.087 paid in respect of the prior Contingent Interest Payment Dates, TD will have paid you a total of $1,095.004 per Note,
        for a total return of 9.5004% on the Notes. No further amounts will be owed under the Notes.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">13</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 12pt; font-weight: bold;">Example 2 &#8212; The Closing Value of at Least One Reference Asset is Less Than its Contingent Interest Barrier Value on Each Contingent Interest
        Observation Date Prior to the Final Valuation Date, the Notes are NOT Automatically Called on Any Call Observation Date and the Final Value of Each Reference Asset is Greater Than or Equal to its Barrier Value and Contingent Interest Barrier Value.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z31f539a2aca645cf88c2afff93e7e083" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: bottom; width: 1%; padding-bottom: 1px;" colspan="1">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 18%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 49%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-top: 3pt;">First through Eleventh Contingent Interest Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">less than </font>its Call Threshold Value and
                Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-top: 3pt;">Twelfth through Thirty-Fifth Contingent Interest Observation Date and First through Eighth Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Call Threshold Value and Contingent
                Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-top: 3pt;">Final Valuation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: 29,400.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: 2,625.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: 7,475.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,000.00 (Principal Amount)</div>
              <div><u>+ $7.917</u> (Contingent Interest Payment)</div>
              <div>$1,007.917 (Total Payment on Maturity Date)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">&#160;</td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,007.917 (0.7917% total return)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">Because the Closing Value of at least one Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date prior to
        the Final Valuation Date (and therefore also less than its Call Threshold Value on each Call Observation Date), we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be
        automatically called. Because the Final Value of each Reference Asset is greater than or equal to its Barrier Value and Contingent Interest Barrier Value, on the Maturity Date we will pay you a cash payment equal to $1,007.917 per Note, reflecting
        your Principal Amount plus the applicable Contingent Interest Payment, for a total return of 0.7917% on the Notes.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">14</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; font-weight: bold;">Example 3 &#8212; The Closing Value of at Least One Reference Asset is Less Than its Contingent Interest Barrier Value on Each Contingent Interest
        Observation Date Prior to the Final Valuation Date, the Notes are NOT Automatically Called on Any Call Observation Date and the Final Value of At Least One Reference Asset is Less Than its Contingent Interest Barrier Value and Barrier Value.</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc075cbf5a6634908b496506746265c7c" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: bottom; padding-bottom: 1px;" colspan="1">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 18%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
              </div>
            </td>
            <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 49%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
              </div>
            </td>
            <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
            <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
              <div>
                <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-top: 3pt;">First through Eleventh Contingent Interest Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value
                and Call Threshold Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value; <font style="font-weight: bold;">less than</font> its Call Threshold Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-top: 3pt;">Twelfth through Thirty-Fifth Contingent Interest Observation Date and First through Eighth Call Observation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Call Threshold Value and Contingent
                Interest Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Call Threshold Value
                and Contingent Interest Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$0.00</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">
              <div style="margin-top: 3pt;">Final Valuation Date</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="margin-top: 3pt;">Reference Asset A: 9,800.00 (<font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value and
                Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset B: 2,875.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
              <div style="margin-top: 3pt;">Reference Asset C: 8,125.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest
                Barrier Value and Barrier Value)</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change) =</div>
              <div style="margin-top: 3pt;">$1,000 + ($1,000 &#215; -60.00%) =</div>
              <div style="margin-top: 3pt;">$400.00</div>
              <div style="margin-top: 3pt;">(Payment at Maturity)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 1%; vertical-align: top;" colspan="1">&#160;</td>
            <td style="width: 18%; vertical-align: top;">&#160;</td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 49%; vertical-align: top;">
              <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
            </td>
            <td style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">
              <div style="margin-top: 3pt;">$400.00 (60.00% loss)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">Because the Closing Value of at least one Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date prior to
        the Final Valuation Date (and therefore also less than its Call Threshold Value on each Call Observation Date), we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be
        automatically called. Because the Final Value of at least one Reference Asset is less than its Contingent Interest Barrier Value and Barrier Value, on the Maturity Date we will pay you a cash payment that is less than the Principal Amount, if
        anything, equal to the Principal Amount plus the product of the Principal Amount and the Least Performing Percentage Change,<font style="font-size: 8pt;">&#160;</font>for a total of $400.00 per Note, a loss of 60.00% per Note.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">In this scenario, investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change.
        Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</div>
      <div style="margin: 6pt 0px 0px; font-weight: bold; text-align: justify;">Any payments on the Notes are subject to our credit risk.</div>
      <div style="font-weight: 400;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">15</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Information Regarding the Reference Assets</div>
      <div style="text-align: justify; margin-bottom: 6pt;">All disclosures contained in this document regarding the Reference Assets, including, without limitation, their make-up, methods of calculation, and changes in
        any Reference Asset Constituents, have been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to any Reference Asset. The information reflects
        the policies of, and is subject to change by, the Index Sponsors. Each Index Sponsor, owns the copyright and all other rights to the relevant Reference Asset, has no obligation to continue to publish, and may discontinue publication of, the
        relevant Reference Asset. None of the websites referenced in the Reference Asset descriptions below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The graphs below set forth the information relating to the historical performance of each Reference Asset. The graphs below show the daily historical Closing
        Values of each Reference Asset for the periods specified. We obtained the information regarding the historical performance of each Reference Asset in the graphs below from Bloomberg.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of each Reference Asset
        should not be taken as an indication of its future performance, and no assurance can be given as to the Final Value of any Reference Asset. We cannot give you any assurance that the performance of the Reference Assets will result in a positive
        return on your initial investment.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold; text-align: justify;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt;">We have derived all information regarding the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (&#8220;NDX&#8221;) contained in this document, including, without limitation, its make-up, method
        of calculation and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by Nasdaq, Inc. and its affiliates (collectively, &#8220;Nasdaq&#8221;) (its &#8220;Index Sponsor&#8221; or &#8220;Nasdaq&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt;">NDX is published by Nasdaq, but Nasdaq has no obligation to continue to publish NDX, and may discontinue publication of NDX at any time. NDX is determined,
        comprised and calculated by Nasdaq without regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221;, NDX includes 100 of the largest domestic and
        international non-financial securities listed on the Nasdaq Stock Market<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> based on market capitalization. NDX includes companies across major industry groups including computer hardware and software, telecommunications, retail and
        wholesale trade, and biotechnology, but does not contain securities of financial companies, including investment companies.</div>
      <div style="text-align: justify; margin-top: 6pt;">NDX is calculated under a modified capitalization-weighted methodology. The methodology is expected to retain in general the economic attributes of
        capitalization-weighting while providing enhanced diversification. To accomplish this, Nasdaq will review the composition of NDX on a quarterly basis and adjust the weightings of components using a proprietary algorithm, if certain pre-established
        weight distribution requirements are not met.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of NDX from October 24, 2015 through October 24, 2025. The dotted lines represent its Call Threshold Value of
        25,358.16, which is equal to 100.00% of its Initial Value, and its Contingent Interest Barrier Value and Barrier Value of 17,750.712, which is equal to 70.00% of its Initial Value.</div>
      <div style="margin: 6pt 0px; font-size: 10pt; font-weight: bold; text-align: center;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (NDX)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00004.jpg"></div>
      <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div style="font-style: normal; font-weight: 400;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">16</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 8pt; font-weight: bold;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold;">Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
                </td>
              </tr>

          </table>
        </div>
         </div>
      <div style="text-align: justify; margin-top: 6pt;">We have derived all information regarding the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;RTY&#8221;) contained in this document, including, without limitation, its make-up, method
        of calculation and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by the Frank Russell Company (the &#8220;Index Sponsor&#8221; or &#8220;FTSE Russell&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt;">RTY is published by FTSE Russell, but FTSE Russell has no obligation to continue to publish RTY, and may discontinue publication of RTY at any time. RTY is
        determined, comprised and calculated by FTSE Russell without regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; The Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index,&#8221; RTY measures the composite price performance
        of the smallest 2,000 companies included in the Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index. The Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is composed of the 3,000 largest United States companies by market capitalization and represents approximately 98% of the market
        capitalization of the United States equity market. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor on its website. RTY&#8217;s value is calculated by adding the market values
        of the underlying constituents and then dividing the derived total market capitalization by the &#8220;adjusted&#8221; capitalization of RTY on the base date of December 31, 1986.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of RTY from October 24, 2015 through October 24, 2025. The dotted lines represent its Call Threshold Value of
        2,513.470, which is equal to 100.00% of its Initial Value, and its Contingent Interest Barrier Value and Barrier Value of 1,759.429, which is equal to 70.00% of its Initial Value.</div>
      <div style="margin: 6pt 0px; font-size: 10pt; font-weight: bold; text-align: center;">Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (RTY)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00005.jpg"></div>
      <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div style="font-style: normal; font-weight: 400;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">17</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 8pt; font-weight: bold;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

              <tr>
                <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
                  <div style="font-weight: bold;">S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
                </td>
              </tr>

          </table>
        </div>
         </div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">We have derived all information regarding the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;SPX&#8221;) contained in this document, including, without limitation,
        its make-up, method of calculation and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by S&amp;P Dow Jones Indices LLC (its &#8220;Index Sponsor&#8221; or &#8220;S&amp;P Dow
        Jones&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">SPX is published by S&amp;P Dow Jones, but S&amp;P Dow Jones has no obligation to continue to publish SPX, and may discontinue publication of
        SPX at any time. SPX is determined, comprised and calculated by S&amp;P Dow Jones without regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8212; S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index&#8221;, SPX is intended to provide an
        indication of the pattern of common stock price movement. The calculation of the value of SPX is based on the relative value of the aggregate market value of the common stock of 500 companies as of a particular time compared to the aggregate
        average market value of the common stocks of 500 similar companies during the base period of the years 1941 through 1943. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor
        on its website.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of SPX from October 24, 2015 through October 24, 2025. The dotted lines represent its Call Threshold Value of 6,791.69,
        which is equal to 100.00% of its Initial Value, and its Contingent Interest Barrier Value and Barrier Value of 4,754.183, which is equal to 70.00% of its Initial Value.</div>
      <div style="margin: 6pt 0px; font-size: 10pt; font-weight: bold; text-align: center;">S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (SPX)</div>
      <div style="text-align: center; margin-bottom: 6pt;"><img src="image00006.jpg"></div>
      <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div style="font-style: normal; font-weight: 400;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">18</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 8pt; color: rgb(0, 176, 80); font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative
        authority directly discusses the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the Notes. Some of these tax consequences are summarized below, but we urge you to read the more
        detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplement and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code
        of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of the Treasury (the &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change,
        possibly with retroactive effect. This discussion applies to you only if you are a U.S. holder, as defined in the product supplement. An investment in the Notes is not appropriate for non-U.S. holders and we will not attempt to ascertain the tax
        consequences to non-U.S. holders of the purchase, ownership or disposition of the Notes. Tax consequences under state, local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as
        to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">U.S. Tax Treatment.</font> Pursuant to the terms of the Notes, TD and you agree, in the
        absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to treat the Notes as prepaid derivative contracts with respect to the Reference Assets. If your Notes are so treated, any Contingent
        Interest Payments paid on the Notes (including any Contingent Interest Payments paid with respect to a Call Payment Date or on the Maturity Date) would be treated as ordinary income includable in income by you in accordance with your regular method
        of accounting for U.S. federal income tax purposes. Holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Upon the taxable disposition (including cash settlement) of a Note, you generally should recognize gain or loss equal to the difference between the amount
        realized on such taxable disposition (adjusted for amounts or proceeds attributable to any accrued and unpaid Contingent Interest Payments, which would be treated as ordinary income) and your tax basis in the Note. Your tax basis in a Note
        generally should equal your cost for the Note. Such gain or loss should generally be long-term capital gain or loss if you have held your Notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held
        for one year or less).<font style="font-size: 8pt;">&#160;</font>The deductibility of capital losses is subject to limitations. Although uncertain, it is possible that proceeds received from the sale or exchange of your Notes prior
        to a Contingent Interest Payment Date, but that could be attributed to an expected Contingent Interest Payment, could be treated as ordinary income. You should consult your tax advisor regarding this risk.</div>
      <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is
        of the opinion that it would be reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be
        treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described
        above, as described further under &#8220;Material U.S. Federal Income Tax Consequences &#8211; Alternative Treatments&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described
        above and under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Section 1297</font>. We will not attempt to ascertain whether any Reference Asset
        Constituent Issuer would be treated as a passive foreign investment company (&#8220;PFIC&#8221;) within the meaning of Section 1297 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply upon the
        taxable disposition of a Note. You should refer to information filed with the SEC or the equivalent governmental authority by such entities and consult your tax advisors regarding the possible consequences to you if any such entity is or becomes a
        PFIC.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of
        holders of the Notes. According to Notice 2008-2, the IRS and the Treasury are considering whether the holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what
        guidance they will ultimately issue, if any. It is possible, however, that under such guidance, holders of the Notes will ultimately be required to accrue current income, possibly in excess of any Contingent Interest Payments received by such
        holders, and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary
        or capital and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code should be applied to such instruments. You are urged to consult your tax advisor concerning the significance, and the potential impact, of the above
        considerations.</div>
      <div style="text-align: justify;"><font style="font-style: italic;">Medicare Tax on Net Investment Income. </font>U.S. holders that are individuals, estates or certain trusts
        are subject to an additional 3.8% tax on all or a portion of their &#8220;net investment income&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the
        extent of their net investment income or undistributed net investment income (as the case may be) that when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a
        joint return (or a surviving spouse), $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the
        income tax. You should consult your tax advisor as to the consequences of the 3.8% Medicare tax.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">19</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Specified Foreign Financial Assets. </font>U.S. holders may be subject to reporting
        obligations with respect to their Notes if they do not hold their Notes in an account maintained by a financial institution and the aggregate value of their Notes and certain other &#8220;specified foreign financial assets&#8221; (applying certain attribution
        rules) exceeds an applicable threshold. Significant penalties can apply if a U.S. holder is required to disclose its Notes and fails to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting.</font> The proceeds received from a taxable
        disposition of the Notes will be subject to information reporting unless you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as
        an accurate taxpayer number, if you are a U.S. holder) or meet certain other conditions.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Proposed Legislation. </font>In 2007, legislation was introduced in Congress that, if it
        had been enacted, would have required holders of Notes purchased after the bill was enacted to accrue interest income over the term of the Notes despite the fact that there may be no interest payments over the term of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been
        enacted, the effect of this legislation generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of
        your Notes. You are urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
      <div style="font-weight: bold; text-align: justify;">You are urged to consult your tax advisor concerning the application of U.S. federal income tax laws to an investment in the Notes, as well as any tax
        consequences of the purchase, beneficial ownership and disposition of the Notes arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD and those of the Reference Asset Constituent Issuers).</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">20</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">We have appointed TDS, an affiliate of TD, as the Agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will
        purchase the Notes from TD at the public offering price less the underwriting discount specified on the cover page hereof and will use all of that commission to allow selling concessions to other registered broker-dealers in connection with the
        distribution of the Notes. The underwriting discount represents the selling concessions for other dealers in connection with the distribution of the Notes. TD will also periodically pay another unaffiliated dealer a per Note marketing fee of the
        amount indicated on the cover hereof with respect to the amount of Notes indicated on the cover hereof in connection with its marketing efforts. We or one of our affiliates may also pay a fee to iCapital Markets LLC, who is acting as a dealer in
        connection with the distribution of the Notes. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Conflicts of Interest. </font>TDS is an affiliate of TD and, as such, has a &#8216;&#8216;conflict of
        interest&#8217;&#8217; in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. If any other affiliate of TD participates in this offering, that affiliate will also have a &#8220;conflict of interest&#8221; within the
        meaning of FINRA Rule 5121. In addition, TD will receive the net proceeds from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of the Notes will be
        conducted in compliance with the provisions of FINRA Rule 5121. In accordance with FINRA Rule 5121, neither TDS nor any other affiliate of ours is permitted to sell the Notes in this offering to an account over which it exercises discretionary
        authority without the prior specific written approval of the account holder.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We, TDS, another of our affiliates or third parties may use this pricing supplement in the initial sale of the Notes. In addition, we, TDS, another of our
        affiliates or third parties may use this pricing supplement in a market-making transaction in the Notes after their initial sale. <font style="font-weight: bold; font-style: italic;">If a purchaser buys the
          Notes from us, TDS, another of our affiliates or third parties, this pricing supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or third parties informs such purchaser otherwise in the confirmation
          of sale.</font></div>
      <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
      <div style="text-align: justify; margin-top: 3pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in
        the European Economic Area (the &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer
        within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as
        amended. Consequently no key information document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and
        therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
      <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
      <div style="text-align: justify; margin-top: 3pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in
        the United Kingdom (&#8220;UK&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the
        European Union (Withdrawal) Act 2018 (the &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU)
        2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document
        required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and
        therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">21</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 3pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Information Regarding the Estimated Value of the Notes</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">The final terms for the Notes were determined on the Pricing Date, based on prevailing market conditions, and are specified elsewhere in this
        pricing supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The economic terms of the Notes are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and
        our appetite for borrowing), and several factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated
        intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection with structuring the Notes, estimated costs which we may incur in connection with the Notes and the estimated cost which we may incur in hedging our
        obligations under the Notes. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the
        levels at which our benchmark debt securities trade in the secondary market is expected to have had an adverse effect on the economic terms of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">On the cover page of this pricing supplement, we have provided the estimated value for the Notes. The estimated value was determined by reference to our
        internal pricing models which take into account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates),
        price-sensitivity analysis, time to maturity of the Notes and our internal funding rate. For more information about the estimated value, see &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; herein. Because our internal
        funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade
        in the secondary market is expected, assuming all other economic terms are held constant, to increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and
        Liquidity &#8212; The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.&#8221;</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Our estimated value of the Notes is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which the
        Agent may buy or sell the Notes in the secondary market. Subject to normal market and funding conditions, the Agent or another affiliate of ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary
        market, if any, may exceed our estimated value on the Pricing Date for a temporary period expected to be approximately 3 months after the Issue Date because, in our discretion, we may elect to effectively reimburse to investors a portion of the
        estimated cost of hedging our obligations under the Notes and other costs in connection with the Notes which we will no longer expect to incur over the term of the Notes. We made such discretionary election and determined this temporary
        reimbursement period on the basis of a number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way
        may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Issue Date of the Notes based on changes in market conditions and
        other factors that cannot be predicted.</div>
      <div style="margin: 12pt 0px 0px; font-weight: bold; text-align: justify;">We urge you to read the &#8220;Additional Risk Factors&#8221; herein.</div>
      <div style="font-weight: 400;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: justify;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%;">
                    <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                  </td>
                  <td style="width: 50.00%;">
                    <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">22</font></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Validity of the Notes</div>
      <div style="text-align: justify; margin-top: 12pt; margin-bottom: 6pt;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the Notes offered by this pricing
        supplement have been executed and issued by TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of TD, enforceable against TD in
        accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity
        (regardless of whether enforcement is sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law,
        Fried, Frank, Harris, Shriver &amp; Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition,
        this opinion is subject to customary assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters,
        all as stated in the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="margin: 12pt 0px 0px; text-align: justify;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the Notes has been duly authorized by all necessary corporate action on the part of TD, and
        when this pricing supplement has been attached to, and duly notated on, the master note that represents the Notes, the Notes will have been validly executed and issued and, to the extent validity of the Notes is a matter governed by the laws of the
        Province of Ontario, or the laws of Canada applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding
        up, moratorium and other similar laws of general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of
        equitable remedies, such as injunctive relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability
        of the indenture will be subject to the limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or
        exclude a limitation period under that Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the
        assumption that the senior indenture has been duly authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary
        assumptions about the genuineness of signatures and certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the registration statement on Form F-3 filed by TD on December
        20, 2024.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" id="zb968ca6bed3642a9867bad1f395df722">

            <tr>
              <td style="width: 50%;">
                <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50.00%;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">23</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
  <div style="width: 100%;" class="BRPFPageFooter">
    <div style="text-align: justify;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Oct 27 13:29:45 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">1,085,000.00</ix:nonFraction></span>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
<!-- [WMV6][ESI9UK6POBe3e49GP2BiqsaZk5QYhWusBeeqH45CgOBMnXeisdaNYrsviz8j7u0M9kh1AnWUJlUESj5osKsdcLGruUGqitwjDinvnlnF60rHTYw0BCaglyfRbpBp8uVtdJo7WqGqZYuwWE6ui9n8g3F79J/CYAVuiqJf9djdI0MUvoWZRowW2SqNklPgoxlk2zE0Co8CIJbYy3WVAUkcCe1zsEReC9VNhO2dfAHlEcBwPAMsCzRamvfu1p6ZBEFjxGb754J5nF4lzYrcRwaJYgMo++J6Agb5HLmMDrZ7Rx9l+Y3H6v+NoArVV+IFuRMdSsvmpERdmV582aU46f59EMsXeQyfW3Wso7qYzPUW70UJr7J34AaiZMJa+dWxpkhyd3fdTL7of33Xn5V/dkeRYCXF/R7Jvnqw15zLV97CW3e7bIv0eR1p/itZy+Y0hA8mJQ==] CSR-->
  <xbrli:period>
    <xbrli:startDate>2025-10-24</xbrli:startDate>
    <xbrli:endDate>2025-10-24</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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MVO/^C5OVD/\ PQWQ._\ F7KL_L+//^A-FO\ X;L7_P#*3U_]2.-/^B0XH_\
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M_%.'_J\O_G//_P >3_-_HK_2 HH_XEG_ .JV_P#-;_\ P\'_ !3A_P"KR_\
(G//_ ,>3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $N = # 2(  A$! Q$!_\0
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M)#\D<J2#D8ZUU%G:PV=ND%M&(XEZ*/<Y)^I))S7"_$8 >*O!F/\ G]_]GBH
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M_P"$]TC_ )\_$G_A.:C_ /&*/^$]TC_GS\2?^$YJ/_QBNKHH Y3_ (3W2/\
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M8KJZ* .6B\=Z/)/!$8=<A,TJ0H]QH5]#'O=@J@N\(5<L0,D@<UU(Z5A^,O\
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M)]R22<UPOQ'_ .1J\%_]?O\ [4BKT"O/_B/_ ,C5X+_Z_?\ VI%0!Z!1110
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M>'_^@@/^_3__ !-'_":>'_\ H(#_ +]/_P#$UT5% '._\)IX?_Z" _[]/_\
M$T?\)IX?_P"@@/\ OT__ ,37144 <[_PFGA__H(#_OT__P 31_PFGA__ *"
M_P"_3_\ Q-=%10!SO_":>'_^@@/^_3__ !-'_":>'_\ H(#_ +]/_P#$UT5%
M '._\)IX?_Z" _[]/_\ $T?\)IX?_P"@@/\ OT__ ,37144 <[_PFGA__H(#
M_OT__P 31_PFGA__ *" _P"_3_\ Q-=%10!SO_":>'_^@@/^_3__ !-'_":>
M'_\ H(#_ +]/_P#$UT5% '._\)IX?_Z" _[]/_\ $T?\)IX?_P"@@/\ OT__
M ,37144 <[_PFGA__H(#_OT__P 31_PFGA__ *" _P"_3_\ Q-=%10!SO_":
M>'_^@@/^_3__ !-'_":>'_\ H(#_ +]/_P#$UT5% '._\)IX?_Z" _[]/_\
M$T?\)IX?_P"@@/\ OT__ ,37144 <[_PFGA__H(#_OT__P 31_PFGA__ *"
M_P"_3_\ Q-=%10!SO_":>'_^@@/^_3__ !-'_":>'_\ H(#_ +]/_P#$UT5%
M '._\)IX?_Z" _[]/_\ $T?\)IX?_P"@@/\ OT__ ,37144 <[_PFGA__H(#
M_OT__P 31_PFGA__ *" _P"_3_\ Q-=%10!SO_":>'_^@@/^_3__ !-'_":>
M'_\ H(#_ +]/_P#$UT5% '._\)IX?_Z" _[]/_\ $T?\)IX?_P"@@/\ OT__
M ,37144 <[_PFGA__H(#_OT__P 32-XV\/J,G45 '<Q/_P#$UT=8'C)HY=)^
MPF79+>RI @'+'+#<0/9<FJBN:21,Y<L6S!\.>-K#9?'5+T1DW3M#E7;,9QM[
M5E>./&,6HQ?V=I<@:VEPLTWEMD<CH#VJ#Q&KZ+>3Z58%E+107"2$<YB4]/Q4
M5V?@NUBN-*_M">&)KB^D:9V*#) <E/RX-=KC&D_;6TZ+^OF<2E*HO8]>IF:-
MK/ABRT*VTZ>]BE2-1O\ W#@,V<DXV^O-5M0\6Z1;^*+>_MKAIT>V-O)A6 7]
MXI!Y'8%C^%>A8'I7%?$S2;K4+6TN;3 %F))7.1P N<_FH'XUST6I5/WCT=S>
MM%PI^XM58;'XLT1O$4UPUYB);98U<QO\S;F)QQ]*U?\ A-/#_P#T$!_WZ?\
M^)J#P5(M_P#VCJ9 +W$JQY Y*H@ _/D_C74U%56ER]BZ3O'F[G$>)/%6C7UG
M9VUK>B2>34K$*OEN,_Z7%ZBNW'2L/QE_R"+?_L(V'_I7#6X.E9FH4444 %%%
M% !7GWQ(8#Q5X,S_ ,_F?_(D5>@UYQ\6+2+4-9\*V-T"UM<W)CE4,5)&^+N,
M$?A2=[:%046TI.R_KT/1?,7UH\Q?6N9N_ FA7>EV6GSV\[6MGN\E1=2@KN.3
MDALG\2<4M]X&T.^N;2XN8)VEM8TCB874JX5?N\!L'ZGD]Z5Y=C51H]9/KT7R
MZ_\ #>9TOF+ZT>8OK7/KX.T=-?.M+#,-1+%S)]HDVY(P?EW;>GM4-CX%T*Q>
M]:VMYU-Y$T,V;J5MRMR1RW'U&#1>787+1M\3^Y?/K_79'3>8OK1YB^M<O;^
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M20I>PBFW)_<OG]K[N_D7-:\?0V6H-;V-L+Z-$#M)'+QC!SV/3C\ZMVT4&O\
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M_P!!!?\ OT__ ,30!T5%<[_PFN@?]!!?^_3_ /Q-'_":Z!_T$%_[]/\ _$T
M=%17._\ ":Z!_P!!!?\ OT__ ,31_P )KH'_ $$%_P"_3_\ Q- '145SO_":
MZ!_T$%_[]/\ _$T?\)KH'_007_OT_P#\30!T5%<[_P )KH'_ $$%_P"_3_\
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M+_Z_?_:D5 'H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4'I13)I4AB9Y75$49+,< "@#+DU1D\20:;A2LELTY/<$, /PZ
M_E65KNOQWUNFGZ'>)_:%V0D9VGY5R0S9QVVM7+ZUK%Q]OE\1:='O3>UA&<;L
M +PW''+$XK7\%>'FT_Q#=O<I*QM[>)(G;E2SC=)M./[V?S-=GL8PCSRZ?G_5
MCB]M*;Y(]?R.BT/P[9:1;S)$GF/,0TKO\Q8[<'D\XZG'N:@\'^'X]%T\"2&)
M;QBX>1.K+O)7],5T5%<SJ2::;W.E4HIII;"8%+114&@4444 ,D564A@"",$'
MO7E/A'5%TK6+J34KDI:6T4ELJ[<X"R+C@>[&O6:X_P 7^&?[5O;+[-&(DFD8
M74B*,E< @G\5 KIP\X*\)[,YL1"3M.&Z.:OI;RX\)R:M!YWFKJ4DRR!<'RBN
MW/TQ@5Z<UQ'';^<[J(MN[=GC%0)I\-OI/V&! (%B,2J>>,8YKR+[7?ZW-IVA
MWT[+%%(+=RHZ,"0I]R *TC%8C;1+\OZ1DY/#VOJW^9Z/XOOH6\(W4\,NY9X@
ML++_ !%L ?SK \+RMKVIP6FI+*6TF%DD60Y\R1OE)/KQFH])@E:73O#\;*XT
MZ\DEN2_&Y%960X]]_3VKT&.WB2=YDC02N &<* 6 Z9/?K42<:,7!:M[/^O(N
M*=:7.^FZ"SMHK2UBM[=-D42!$7). !@=:FHHKE.M*V@4444 %%%% !1110 4
M444 %%%% &'XR_Y!%O\ ]A&P_P#2N&MP=*P_&7_((M_^PC8?^E<-;@Z4 9NN
MW\^GVT<MO LP,T<;[GVA%9@N>AR>>GZUG-KMR-5,8MHC8K>"Q:3S#YF\Q[MV
MW&,9(7KGO6OJ>G6^I0"&[\TQA@^(Y7CY!R.5(/6JIT&R2X^TPHXN-WF!GD=U
M\P)L#E2V"V.,]?>@"I<:Y<)J<\<4$;6=M<PVDSLY#[Y A!48P0/,3J?7TYS[
M?Q7<S):8M80VH11S669#C8S8_><<$ @\9SR/>MBS\/64'DO)Y\\\80M+),Y\
MUT& [KG:S<#DCL/04L?AO2XXRB0.JG:%Q,^4"MN4(<Y0 ]EQ0!-X?U%M3T\S
MRQB.5)98)%5MP#QNR-@]QE<BO/?B1XAT8>+/"BG5M/#VU\1.IN4S$1)'D-S\
MN,'KZ&O3+&S@L+98+5-D2DG&2222222>22222>I-</\ $?\ Y&KP7_U^_P#M
M2*@#I/\ A+_#7_0PZ/\ ^!L7_P 51_PE_AK_ *&'1_\ P-B_^*K<HH P_P#A
M+_#7_0PZ/_X&Q?\ Q5'_  E_AK_H8='_ / V+_XJMRB@##_X2_PU_P!##H__
M (&Q?_%4?\)?X:_Z&'1__ V+_P"*K<HH P_^$O\ #7_0PZ/_ .!L7_Q5'_"7
M^&O^AAT?_P #8O\ XJMRB@##_P"$O\-?]##H_P#X&Q?_ !5'_"7^&O\ H8='
M_P# V+_XJMRB@##_ .$O\-?]##H__@;%_P#%4?\ "7^&O^AAT?\ \#8O_BJW
M** ,/_A+_#7_ $,.C_\ @;%_\51_PE_AK_H8='_\#8O_ (JMRB@##_X2_P -
M?]##H_\ X&Q?_%4?\)?X:_Z&'1__  -B_P#BJW** ,/_ (2_PU_T,.C_ /@;
M%_\ %4?\)?X:_P"AAT?_ ,#8O_BJW** ,/\ X2_PU_T,.C_^!L7_ ,51_P )
M?X:_Z&'1_P#P-B_^*K<HH P_^$O\-?\ 0PZ/_P"!L7_Q5'_"7^&O^AAT?_P-
MB_\ BJVR<5PGBWQ(TES)9Z5-*DEG_I%Q(@X*J1E0?J>?IBKITW4=D9U*BIJ[
M.@_X2_PU_P!##H__ (&Q?_%5SOBKQ#H&LQP:8-7MEMI9 TUTLR>4B@$@;R=N
M2V!CZUUFL:K#I>D37TN'2--R@'[Y/0#ZUE^$]+;=)K5_L?4+X*YVC(B7'"KG
MGIC/TJJ?NKVC^7J34?._9KKOZ%>QUCPC;:3!I[:[HDL,:*IW7D7SD8Y(W=<C
M-: \7>&A_P S#H__ ('1?_%5O45FVWJS5))61A_\)?X:_P"AAT?_ ,#8O_BJ
M/^$O\-?]##H__@;%_P#%5N44AF'_ ,)?X:_Z&'1__ V+_P"*H_X2_P -?]##
MH_\ X&Q?_%5N44 8?_"7^&O^AAT?_P #8O\ XJC_ (2_PU_T,.C_ /@;%_\
M%5N44 8?_"7^&O\ H8='_P# V+_XJC_A+_#7_0PZ/_X&Q?\ Q5;E% &%_P )
M?X:_Z&'1_P#P-B_^*K*;4?!3:E]O.LZ+]IW^9N^W1\L!@'&[TKLJ*:;6PG%2
MW.4AUOPA#J4M_'K>C+=S($DD%_'\P'MNQV%7AXO\-?\ 0PZ/_P"!T7_Q5;M%
M#;>X));&'_PE_AK_ *&'1_\ P-B_^*H_X2_PU_T,.C_^!L7_ ,56Y12&8?\
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M\-?]##H__@;%_P#%4 ;E%8?_  E_AK_H8='_ / V+_XJC_A+_#7_ $,.C_\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!A^,O^01;_\
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MAT?_ ,#8O_BJW,48H P_^$O\-?\ 0PZ/_P"!L7_Q5'_"7^&O^AAT?_P-B_\
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MU_T,.C_^!L7_ ,51_P )?X:_Z&'1_P#P-B_^*K<Q1B@##_X2_P -?]##H_\
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M+_XJMS%41IL7]M?VEE_.^S_9]N1MV[MV>F<Y]Z */_"7^&O^AAT?_P #8O\
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MH50 ,#I2T %!.**Y37M7EN&-I9VM^5$A4R1$1_:-F?,CC;.0XP3R #M(![T
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M-TTCQ(%VI$K.S  9Y;YN6_E6S0 4451UP7C:1>#3"!?&)O)SC[^..O'7UXH
M75;T6=M\I4W$G[N!#D^9(0<#CGMD^@!)X%95C>W&JS26-X@M)5BD6X@V,QR>
M%*OPI7!Z]SG@;2*Q(;==3U2Q33;G58P@9YS.S-):2 8# R9 8Y92G*D'(' -
M=K86WV2UCB,LLS+G,DIRS$G))Q@=3T  '8"@"#1=,32[,0K++.QP7EE.6<X
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MR21E"K$'>/O9XZ<?4&MVTMX[6WC@A&(XU"J"23@>YY-2@8HH ***RO$_VO\
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M;]'9V",HR95W91<. 5*C:P.,$'CM=-LC9V_ER7$URY8L\LQ&YB?8  >F  *
M(-$TB/2H619I9V9L[I#T'.% Z #/]36G110 5#=7$5M;R33R*D:+N9CV%35P
M5XGVIFM+B;41JK76R2#?)Y4L)DZJ/NA0F"&7!4J,G.00#8AUF]>\2VNX$LWE
ME!@+!W$T.>2.!A\8RIQMSGG&*OZ/HL>FS7,HGEF::6210^,1AY&D*J!_M,>>
MIX]!4^E:>]E&_G7ES>2.<F6<KG &  %  _+ZU?H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &$ C(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W_7/$,^G^
M(M/T^&YL'DNI8U%DR-YS(20T@?=@ 8)QM.=N.IK2UZ_NK>XT^STXP+=7DC+Y
MDZ%UC54+$[0RDG@#&1USVIFK:"^J3H+B_E^Q++'-]G$:9W(0PP^,@9 )[]>0
M*J1Z1J-^B7-_>FWOX;N2>V,:*PAB8%1&>/F^4Y)ZY/7B@#-A\3ZO>QW26D=C
M%=:?#))="6-V61DEECVIAAM!\ECD[L9'!I;KQ9?3PZE=Z7';+:Z9:174Z3HS
M/+NC\PJI# +A,<D-R>G%7?\ A#TCC9;34;F!IH7ANI-JLTX9V<GD?*VZ1\$=
M-W3I3[SPA;S2W(MKJ:UM;R%+>[@C4$2H@V@ GE3M.TD=O?F@#I8W#QJXZ, 1
M7-3?$+P7#*\4WB[P['(C%61M3A!4C@@C=P:Z;: H4< <"O+_ !3HFECXO^!H
MO[-LO+FM-4:1?(7#D"WP2,<D9/7U- '3_P#"QO!'_0X^&_\ P:0?_%4?\+&\
M$?\ 0X^&_P#P:0?_ !5:G_"-Z'_T!]-_\!4_PH_X1O0_^@/IO_@*G^% &7_P
ML;P1_P!#CX;_ /!I!_\ %4?\+&\$?]#CX;_\&D'_ ,56I_PC>A_] ?3?_ 5/
M\*/^$;T/_H#Z;_X"I_A0!E_\+&\$?]#CX;_\&D'_ ,51_P +&\$?]#CX;_\
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M  C>A_\ 0'TW_P !4_PH_P"$;T/_ * ^F_\ @*G^% &7_P +&\$?]#CX;_\
M!I!_\51_PL;P1_T./AO_ ,&D'_Q5:G_"-Z'_ - ?3?\ P%3_  H_X1O0_P#H
M#Z;_ . J?X4 9?\ PL;P1_T./AO_ ,&D'_Q5'_"QO!'_ $./AO\ \&D'_P 5
M6I_PC>A_] ?3?_ 5/\*/^$;T/_H#Z;_X"I_A0!E_\+&\$?\ 0X^&_P#P:0?_
M !5'_"QO!'_0X^&__!I!_P#%5J?\(WH?_0'TW_P%3_"C_A&]#_Z ^F_^ J?X
M4 9?_"QO!'_0X^&__!I!_P#%4?\ "QO!'_0X^&__  :0?_%5J?\ "-Z'_P!
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M(WH?_0'TW_P%3_"C_A&]#_Z ^F_^ J?X4 9?_"QO!'_0X^&__!I!_P#%4?\
M"QO!'_0X^&__  :0?_%5J?\ "-Z'_P! ?3?_  %3_"C_ (1O0_\ H#Z;_P"
MJ?X4 9?_  L;P1_T./AO_P &D'_Q5'_"QO!'_0X^&_\ P:0?_%5J?\(WH?\
MT!]-_P# 5/\ "C_A&]#_ .@/IO\ X"I_A0!E_P#"QO!'_0X^&_\ P:0?_%4?
M\+&\$?\ 0X^&_P#P:0?_ !5:G_"-Z'_T!]-_\!4_PH_X1O0_^@/IO_@*G^%
M&7_PL;P1_P!#CX;_ /!I!_\ %4?\+&\$?]#CX;_\&D'_ ,56I_PC>A_] ?3?
M_ 5/\*/^$;T/_H#Z;_X"I_A0!E_\+&\$?]#CX;_\&D'_ ,51_P +&\$?]#CX
M;_\ !I!_\56I_P (WH?_ $!]-_\  5/\*/\ A&]#_P"@/IO_ ("I_A0!E_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y3X:?\B[>?\ 89U;
M_P!.-Q75URGPT_Y%V\_[#.K?^G&XH ZNBBB@ HHHH **** "O/\ Q5_R67P#
M_P!>>J_^@VU>@5Y_XJ_Y++X!_P"O/5?_ $&VH ] HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Y3X:?\B[>?]AG5O_3C<5U=<I\-/^1=O/\
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MCSO,^V>:_F;<?<_U?3OZ_A0/#GQ)_P"$?.G?\)%I_P!H\[S/MGFOYFW'W/\
M5]._K^%'._Y?R_S#V%/_ )^K>VTMN^VWX^1ZQ17D]OX<^),6A7-@WB+3WGED
M#+=F63?&.,J/W?0XHM_#GQ)BT*YL&\1:>\\L@9;LRR;XQQE1^[Z'%'._Y?R!
MT*>O[U;VVE]^VWXGK%%>3Z?X<^)-KI-_:2>(M/GEN-OEW+ROO@QUV_N^_O\
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M_P!!.R_[_I_C58AJ*5*/3?U)P\7)NI+KMZ&A7*?#3_D7;S_L,ZM_Z<;BMO\
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M_P# ./\ PK;HH Q/^$2\.?\ 0 TC_P  X_\ "C_A$O#G_0 TC_P#C_PK;HH
MQ/\ A$O#G_0 TC_P#C_PH_X1+PY_T -(_P# ./\ PK;HH Q/^$2\.?\ 0 TC
M_P  X_\ "C_A$O#G_0 TC_P#C_PK;HH Q/\ A$O#G_0 TC_P#C_PH_X1+PY_
MT -(_P# ./\ PK;HH Q/^$2\.?\ 0 TC_P  X_\ "C_A$O#G_0 TC_P#C_PK
M;HH Q/\ A$O#G_0 TC_P#C_PH_X1+PY_T -(_P# ./\ PK;HH Q/^$2\.?\
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M^B7W_P# '"&&?+S3DN_NK3M;WM?P]#I_,P><"N<\=N)M#^P_QWL\5NF!G!+
MY_(&H]9^'OAK6A:#4M/:;[+"((?](D7:@Z#AAGZGFL/QAX.T34M>\,V=Y8F:
M%8Y(!^^D!6-$^49#>I'/7WK2FZBG=):>?_ ,Y0PKBE.<E?>T4[=K>]K^%O,[
MG3;=-/T^UM$<LD$:QAFZG Q5GS,8R1CUKF=4^'WAK5;.QMK_ $]IH;*/RX%-
MQ(-B^F0W/3OFC5/A[X:U2SL;6_T]I8+&/RK=?M$@V+Z9#9/3OFH<JC;=E]__
M  "X4\,N5.<O/W5HNEO>U_#YG3F3&.GUI#+C'(QZUS>H> /#>HZ78Z=>6#26
M=ED01_:)!LSUY#9/XYIM]\/?#5]I-CIEUI[/966[R(_M$@V;CD\ALG\<T7GV
M7W_\ (PP^G-.6^ONK;O\6K\M/4Z<RXQR/K09>G(QZUS=YX#\.WFAVFCW-BSZ
M=:L6AB\^0;2<]PV3U/4TR?X>^&I]#M]'ET]FTZWD,L<7VB0;6.<G.[/<]31>
M?9??_P  %##Z7G+?^5;=_BW\MO,Z<R<=OK2&7C@CZUSDG@+PY)X?CT1[!CID
M;^8L/GR<-R<[MV>Y[TS_ (5[X:_L'^Q?[/;^S?.\_P G[1)]_&,YW9_#.*5Y
M]E]__ !0P_6<M_Y5MW^+?RV\SH[C$L$BY'S*5_.O(/ 16/4+2YG?:BW.PL[<
M*!#)CZ#FN]7P#X<3P_)HB6##3&D\XP_:)/O\<[MV>W3.*\^\0>#K#1_AXEJ+
M)H6FU M*AD8EL>8%/7T Z5UX:=2SII+WO/\ X!RXBEA;JHYR]U_RK:ZU^/?R
M_$] \.NUSXBU^]5T>W9XX(V#9'RKS_Z%6'X(,N@SZS8WY2*3(EA#'_6</ROM
MA<U6^'G@O2Y?!M]INHV;&WGNB9(?-=3E0N.0<]JY7Q]X3T;P_J"V.CVC6]M<
M0!I4\YVW'<PZDD_E6E-5)U'1LM5W[?(SJ1PD::J\\M_Y5L][^]OY?B7=%L%_
MX1LZO&3'=6E\N90V"(R%S^IS^=>@Z"MO?>)=5U6)_,5=EM%(&^4KL5F_7'-4
MK'X>Z':^%;[3+*S,"ZA"HG!FD8,X'!Y;C!]*K> _ &EZ;X;N;>ZL9(Y[Y&BN
ME,S_ #H"0._''/'/-14Q%2HFVDOG_P #R-(8;"TW:,Y/:WNK7S?O:/7;7;<F
MO_$D'A_6M9DE43/++ !&K -M\OEAZX_K4'B;Q5!JGA18H4DBGOG^SA#_  ,"
MN[/M@X_&LUOA;H]OXB2.TL'31KB$B=5G<_,,\$DD@'CI57PQ\*K*WUC4#>VA
MBLR"D:I,_P ZD@CG/8<'WJH2C:,I)76^K]%T_P B9TZ/OQC.5NGN+U=_?T\M
M[^1Z%H&B6^C37TL#%Y+N0R.3V]%'L,G\ZS/&"6FEV5OJD,$:R6UVDSF-0"VX
MX;/U!J31?A]X:T4W1TS3VA^U0F";_2)&W(>HY8X^HYJDOPT\-Z9:7K:-IOE7
M<UN\(+7$C Y'&0S$=0*YH5:GM%*:]=?^ ;U*&$5.4:<I:+3W5^/O:?B7O%NL
MK_PC>[3T6\^W'[+&$;J74C/Z&M[3$-OI]M"V T<2H0/4 "O$O!OABQT[QCI]
MLMFT5XCR)<?O&/&#[XZ=Q7IFA_#SPQH>I)?Z7IS07:@@/]HE;@@@\,Q'>KK0
MJ4E&%EWW^78FG]5J2G.,Y:6M>*6O6_OZ?B=2)<^F?2@2Y[CZ5S.C_#[PUH^K
M#4].T]H;T;OWGVB1OO @\%B.YIFE_#GPOI>K)J=CIS17J,763[1*V">O!;'<
M]JY[S[+[_P#@'0X8;6TY;:>ZM^WQ:+SU?D=4)?<9]*02^I KF;/X>^&K+7/[
M8MM/9-1\QI?-^T2'YFSDX+8[GM5:3X8>$I=1:^?2V-TTAF,GVJ4?/G.<;L=:
M+S[+[_\ @!R86_QRV_E6_;X]O/\  Z_S><9 H\WG&0*YG6OA[X:UK53J6I:>
MTUZ=N9/M$B].G 8"C6OA[X:UK53J6I:>TUZ=N9/M$B].G 8"AN?9??\ \ 48
M8;3FG+;7W5OY>]JO/3T.G\WGJ!7*>,+*'4-6T%+E0\7GNK(1PPV9Y_[YJ;Q#
MX \-^(;\7NL6#7%RJ! _GR)P.G"L!3=<^'OAK7;N.YU73VGGCC6)6^T2+A1T
M'RL*N,ZD'S12^_\ X!+HX6HHJ<Y>?NK3M;WM?G;T.EWA>. *4RX/) KG/$'@
M+PYX@F@EU>P:XD@C\J,^?(N%]/E84S6?A[X:UH6G]I:>TWV2$00_Z1(NU!T'
M##/U/-0W/6R7W_\  *A##>[S3DN_NK3M;WE?\#IS)@\X ]:YCX9G_BG;O_L,
MZM_Z<+BG:UX \-ZU%9QZG8-,EI$(81]HD7:@X X89^IYJM\)[6&R\(O:6R[+
M>WU34X8ER3M1;^=5&3R> .M4N:^J,YQI*"<)-RZJUE]]W^2.RHHHJC(****
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M[D_^1JZNB@#E/[2\9_\ 0MZ'_P"#N3_Y&H_M+QG_ -"WH?\ X.Y/_D:NKHH
MY3^TO&?_ $+>A_\ @[D_^1J/[2\9_P#0MZ'_ .#N3_Y&KJZ* .4_M+QG_P!"
MWH?_ (.Y/_D:HOA2TS^$Y6NXTBN&U;5#+'&^]4;^T+C(#$#< >^!GT%=A7*?
M#3_D7;S_ +#.K?\ IQN* .KHHHH **** "BBB@ KS_Q5_P EE\ _]>>J_P#H
M-M7H%>?^*O\ DLG@'_KSU7^5O0!Z!11FB@ HHHS0 4A.*JZCJ-KIMLUQ>S+#
M$O5F_D/4UAZ;XRTO4=0CMHGD1I0#$77&\Y(Q[=._K5QIRDKI:$2J1B[-ZF9X
M[N6U/5M/\.PDHT[K+)*O.P#=@8_ G\*IP^!+]-0MXI-4,NF(_FL&!!8E@2N,
M]\#G/X5T?AZ))M6UN[=5:87@B#'LJQK@#_OH_G71 5M[>5-*$.WYF"HQJ-SF
M>>^(? 4T^KF\T>XCM0_SE<E=K^V/7FM2S\$64=QIMP^!+:QJ'\L8\R0$'>3W
MZ'CWKKZ*EXFHTE<M8:FG>Q#/ L\+Q. 4=2K#U!ZUE>%O#\>@6DT*2&9I)"V\
MC!V]%'X 5MT5DI-)QZ,U<(MJ5M4 HHHJ2@HHHH ****  UPGQ.2=H]/%FADN
M)C);!1U(=1D?H*[NL;7M-DO;O2IH<9M;H2/DX^7:0?Z5I1DH34F95HN<'%&K
M$,*H'0#&*DI%Z4M9FH4444 %%%% !6!H9QKWB%?^F\3?G$O^%;]<S8W,5EK'
MB2>Y<)%&\+LQ[#RA5PV:_K=&<]T_ZV.?U"[;Q%KDVAR2*#%/.5)7A5$6U?K\
MS,?PKM]'TR'3+00PJ 2=SD9^9CU/->>^#5\_XB:C<\&)Q/+$P.0R^9MR/;K7
MJ-;XGW&H1VLC'#>_><M[A1117*=04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5RGPT_Y%V\_[
M#.K?^G&XKJZY3X:?\B[>?]AG5O\ TXW% '5T444 %%%% !1110 5Y7\3]0ET
MKXD>"[Z"(2M#9ZD2I..";8'^=>J5YOXXM8KWXL>![6Y7?!-9:H'7.,C%L>U5
M!Q4DY;$S4G%J.YN^#_$K:LMW]NV0,LR^4I&W,;_<ZGDG!KJQTKSWQ=X=-I?V
MVLVS1I:V"1$Q<Y^1QT]MO\O>N\N+B*UM7GG8)%&I=F/8#J:TJQAI*'7IV,J,
MI*\9]"1G"#+$ >]86J>)K'3=:BL+MPADCW[\\*<X (]^:Y#6]>?Q5?3:=I1G
M6V@B><-']Z9T&5&/3=^?%5+BVDU3P9J^J:I"?[1$Z@,1M9=@5.G;JW%:PPR7
M\73_ ()C/$MW]G_5CHM'T>7Q%-#K.LW GMB6:WL\$(@#?*3SUP.1_P#JJ2]\
M$VD>FWJ6),=T\AN(91A6C;'"!O[O7\ZZ/P]:K9:)9VZ!E"1*,,>0<<U?(S6<
MJ\U+W7H:QH0<?>6IR7PS$SZ!)<7!):><MDMDG:JH23[E3775';P16T0B@C2*
M,$D*B@ 9.3P/>I*SG+GDY&M.')%1"BBBH+"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *\U\6:G#9ZEXCLIRP>\MXS%@<9"G.3V[5Z57D'Q+@5O
M&5NK<K-%'N_[Z(_I77@HJ52TNWY')C).,$UW.Z\":8;'P[9?:8%CO C!B5^8
M*7+!3W[]/6NEI%  P*6N:<G.3D^IT0@H144%%%%26%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %<I\-/^1=O/^PSJW_IQN*ZNN4^&G_(NWG_89U;_ -.-Q0!U=%%% &1=:QY&
MN6>FFVG/VD-B? $8(4MCU)X[# ]:EUG4S8&UBAMWN;JZD,<42L%SA2Q))Z
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MJLT9KE?^%=>#/^A5T3_P"C_PH_X5UX,_Z%71/_ */_"@#JLT9KE?^%=>#/\
MH5=$_P# */\ PH_X5UX,_P"A5T3_ , H_P#"@#JLT9KE?^%=>#/^A5T3_P
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M:,URO_"NO!G_ $*NB?\ @%'_ (4?\*Z\&?\ 0JZ)_P" 4?\ A0!U6:,URO\
MPKKP9_T*NB?^ 4?^%'_"NO!G_0JZ)_X!1_X4 =5FC-<K_P *Z\&?]"KHG_@%
M'_A1_P *Z\&?]"KHG_@%'_A0!U6:,URO_"NO!G_0JZ)_X!1_X4?\*Z\&?]"K
MHG_@%'_A0!U6:,URO_"NO!G_ $*NB?\ @%'_ (4?\*Z\&?\ 0JZ)_P" 4?\
MA0!U6:,URO\ PKKP9_T*NB?^ 4?^%'_"NO!G_0JZ)_X!1_X4 =5FC-<K_P *
MZ\&?]"KHG_@%'_A1_P *Z\&?]"KHG_@%'_A0!U6:Y3X:?\B[>?\ 89U;_P!.
M-Q2_\*Z\&?\ 0JZ)_P" 4?\ A4/PIMH;/PG-;6D20V\.K:I'%%&NU44:A< *
M .@ &* .PHHHH *  .E%% !1110 5Y_XJ_Y++X!_Z\]5_P#0;:O0*\_\5?\
M)9? /_7GJO\ Z#;4 >@48HHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_740R)+&LD1#(P#*PZ$'H:?0!RG_  @>D_\ /YXD_P#"CU'_ ./T?\('I/\
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M_/$G_A1ZC_\ 'ZZNB@#E/^$#TG_G\\2?^%'J/_Q^C_A ])_Y_/$G_A1ZC_\
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MI]!ZF@#B]*\!1C4]8_M#4/$36C7"FQ \1W^5B\F,,#B;/^L\P\Y//IBM3_A
M])_Y_/$G_A1ZC_\ 'ZZ:UGANK>.>V=)(95#HZ$$,IY!!'6I: .4_X0/2?^?S
MQ)_X4>H__'Z/^$#TG_G\\2?^%'J/_P ?KJZ* .4_X0/2?^?SQ)_X4>H__'Z/
M^$#TG_G\\2?^%'J/_P ?KJZ* . \1> HVT]5T6_\1)=_:+<EF\17Y'E><GFC
MF8]8]X_'C!YK4_X0/2?^?SQ)_P"%'J/_ ,?K=M]5L;G4;FPAN(WO+8*9H0?F
M0, 1^A'YU>H Y3_A ])_Y_/$G_A1ZC_\?H_X0/2?^?SQ)_X4>H__ !^NKHH
MY3_A ])_Y_/$G_A1ZC_\?H_X0/2?^?SQ)_X4>H__ !^NKHH Y3_A ])_Y_/$
MG_A1ZC_\?J?X?Z-+X?\ #S:=/O)2^OID+S-,QCDNY9(RSL2S-L=<DDG.<DFM
MFXU"UM[JWMI9<7%P2(XP"6; R3@= /7IT]15H$9XH 6BBB@ HHHH *"<4$XZ
MUQ.M:X-8M4M[.TOFCD83QAE\M;^%2"ZQL#G)4Y ;;N ],T 7M<U"UOKJYT+5
M;>>*QNE%NMWG:CR,,^7GL<$8)X)R.HP:IL=1M-4TU$U'4[R]$BM-(4V6OD#(
M(*@;-V!QC+;L'@55TM+;5?M^D:;<FXTFXMBVV=&<V4F0-AW<\YW!3RI4]L5V
M&E:?#IMC%:P;S&@^](Y=F)Y+,3R22<DT 7%Z"BBB@ H)Q16)K?B"WTN=HGMK
MRY,<8FG-O%O$$9) 9N1_=;@9/!XH FU[4Y--MHY8+.>]=Y GE0_>Q@LQY] I
MX[G ZFN8U""6]N?[1TYKN_T/4 ))8K";RIEE"A%8-N4[<+RN00PYSR*HQ3C3
MF5Q-/'KZR@A2S-'JL;-QM['(/&.4(_N]>QTO0;>RU:^U%<M-=.6VCA(P0,X7
MIDE02W4X'I0!)X7COH="M8]6=GO%4AV=@S8R=NXC@MMP"1U.:U:** "BBJ>K
M:A%IMKYTPD?+!$CC7<\C$X"J/4D_U/% %O<!7,Z+?V6OW$<]W926VIP0G%O<
M?>6*3'S =""!C/4<@]Q6)J.H6.JW_P!LU 7D>GQK]E<AFCDTZY4DEG"GC<&3
M#\@;1SAJT=.TP>)+#3KC4I/.%G-(JS(NPW<8)522/X&&"R]&(';B@#8\)V]Q
M9:0MC=(P^R.UO"Y.?,A4_NV_[YV@^X-;-&,44 %%%!.*  G%<WKFK6YOIM(U
M&">.PNH1";S.(P\FX>63_"2.AZ9..#C.9X@U=]:@6TTN"[)$GGJKYA2_AC.)
M$C<'.>01G ..X)-1:1]DO[BZTK2Y6FTNZM)#);W,9?[#+E0%*MR VXG83_ <
M<&@!MIIVKVOB)PESJ,L@F@ N&6-8'ME4;@P 'SY,@ '.2IZ9KO5Z<U1T72X=
M)T^*T@,CJ@YDE<N[GNS$]2:OT %%%% !69KVI2:;9K-;V<U[(SA1##C<1U)Y
MXX )QWX'>H-<\06VDS&.:*YEV1^=.T,>X01Y(WOSP.&Z9/RDXX-<7'*-)A4L
M;FV\2VY 8.S-'JW/.WJ&W=OXD)]!R :E_IT.L65]>07AN-$U!TN9H(;=GN#(
M@5=J,#E3F-<@C((/([=;H:W2Z/9+J)!O1 @G([R;1N_7-4M/T"WM-9O=3&3-
M<MD*.$C&!D@=-QP,MU. .U;5 !1110 5'-*(XV?DA020!DG\*@U6^BTVS>YG
MWE5(4*B[F=B0%4#N22 /K7$:C>V6HZB]WJ\%]'IRH+8DET>PG4ECOV'Y0RLA
M#@D<#)P: +MU>:IJES:!M/CL]0MQ_:%E')-O69,&-XY/E&Q\2#ID L#DX(K0
M\+0SC5-2N5L)]/M+D)(T$Y7)GYWNNTD8(V9/<C/J3FZ;IDGB)+6>ZOY)[6T,
M]KYB#;]OA9HR"6';,8#8X;!Z XKME  X&* %HHHH *"<=:"<5QFOZV-4A:RL
M;>[?,FY<CRTO5C;][$CYSG /7 .#SC)H OZIK]U:75QY>FR/I]JZ1W%R[["-
MV/FC7'SA=PR<COC.*III-UX?O;6'PQ&IMKD;)H9L^7%M4#SMPZ$X *_Q'!XP
M369:+;Z@]SI.A7\KV-]:R+)!,&<Z?(,8.&Y4')&PD<CC'-=MI.GIIUKY2O)+
M(S%Y9I#EY7/5C_@. , <"@"XN<<]:6BB@ HHK'US7K?29 DD%U<,(S-(+>/?
MY48X+MST]ADG!P#B@"76+VZMQ#'IUI]JN)F*@.YCC0 9+.X!P.W0DYKGKW9>
M^&KZ_AL)4U#[7'--"F97$T$B+A?48CXQC(.>YK$DN/[,ADF2[EM_$,;&1-Y:
M2/54)RN!R#D8''*'VZ]AI&@BUU*YOYIY)7DD:2&)N%@W8W8'=B>Y[<#'.0#3
MTF6[FLQ)?PI!,Y+")3N*+V!/0MCKCCTSU-RBB@ HHJKJ=]%IUE)<W&[RTP,*
M,LQ) "@=R20 /4T 27<XM[:68J["-2Y5%W,0!G@=S7.6]U=7VJ06^JZ=%9W:
MQ/=V3"8S*, (V\87YAY@X&1SP:Q]2O;34M0-UJL5];Z>B"U<EFC?3YP2V]MA
MX#*R8?) VCU-6M-T^X\2VUI-?74GDVCSVQEC&W^T(24P^1]T-M&<=><8!% %
M_P (V-SIUW<6B3WDNF01)$AND"YE!.XH  =N,>Q[=S744B*$4*H  & !VI:
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MKZ'4/[84^;/>!2IMW /SQR%=A4DX51D%6.1U% &GJ4>HW\6D7FCV:121RO\
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M+DG ].U;(&.E%% !1110 5GZ_IW]JZ7-:"1H78J\<BC)1U8,C8[X90<5H44
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &) C4# 2(  A$! Q$!_\0
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M4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\
MP<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO
M_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >
MH ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ]
MHKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_
M /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4
M_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#
M?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+
M4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\
MP<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO
M_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >
MH_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4
M_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#
M?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+
M4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\
MP<WO_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO
M_P >H ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >
MH ] HKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ]
MHKS_ /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_
M /X4_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4
M_P"#?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#
M?^?+4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+
M4O\ P<WO_P >H_X4_P"#?^?+4O\ P<WO_P >H ] HKS_ /X4_P"#?^?+4O\
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MVFD7\6IZ39W\.1%<PK,H;J PS@_G7%?%8YU+X?XY_P"*F@_])[B@#T&BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE/!O_(Q^.O^PS'_ .FZ
MRKJZY3P;_P C'XZ_[#,?_INLJ .KHHHH S-4TUM0NK!I)<6]M-Y[1;<^8P!V
M9.>@)W=.H'I6=>:?JFJR7RW$B6D,-S#+I[;0Y!CP2S@'E6.1MR#CTS7244 <
MHOAF\BO!J,&HQ#5VDD>69K4M$ZNL:[1'O!  BCQ\QY!ZYI(O"DMC):SZ1?B"
MZBM39RR30^;YBEM^[ 9<-N+$=1R>*ZRB@"II-A%IFE6EA!N\FVB6%"QY(48&
M??BO+/C#X8\.#6/"%[<Z1I@EN_$,27D\D"9F0P3DAV(Y&54\^@KUZO-_C-9P
M7\O@>TNXQ+;W'B.&.1&Z,IM[C(_2D[VT*AR\RY]B^?!G@#[-]H&@>'/(SCS/
MLT6W/UQBC_A#/ 'V;[0-!\.&#./,^S1;<_7&*U_^$)\.?V2=,_LFV^P&7S_)
MV\;\8W?7%'_"$^'/[).F?V3;?8#+Y_D[?EWXQN^N*CW_ "_KY&[CANCEOV6W
MW[_U<R%\&> 'MFN$T'PXT"G#2"VB*CZG&*%\&> 'MFN$T'PXT"G#2"VB*CZG
M&*UXO!/AR+2YM.CTFV%E,XDDBV\,PZ&B+P3X<BTN;3H])MA93.))(MO#,.A-
M'O\ D#CAM;2EOV6WW[_U<R(_!G@"6!YHM!\./$GWW6VB*K]3CBB/P9X E@>:
M+0?#CQ)]]UMHBJ_4XXK7M?!/ARTT^[LK?2;9+6[V^?&%XDV],_2BU\$^'+33
M[NRM])MDM;O;Y\87B3;TS]*/?[(''#:V<M]-%MUOKN9$/@SP!/'(\&@^')5C
M&79+:(A?KQQ1#X,\ 3QR/!H/AR18QEREM$0OUXXK7L?!/ARPM[J"TTFVBBND
M\N=0N?,7T-%CX)\.6%O=P6FDVT45TGESJ%XD7T-"Y_()1PWO<LI=+:+YWU^X
MR+?P;X N=_V?0?#<NP9;9;1-M'O@46_@SP!<;_L^@^')2@RVRVB;:/? K7TW
MP5X<TS[1]@TFVA^T1&"7:OWT/53[4:9X)\.:7]H^P:3;0_:(C#+M7[Z'JI]C
M0N?K8<HX;WN64O+1?.^ID6W@WX?W3%+;0?#<SJ,E8[:)B!^ HMO!G@"Y<I;Z
M#X<ED49*QVT3$?D*U]*\$^'-)N&GT[2;:"5D,995ZJ>HYHTOP3X<TJX:?3M)
MMH)F0QEE7JIZCGUH7/UL$HX;WN64O+1?.^ID6W@SP!<R&.WT'PY+(!DK';1,
M1^0HA\&> )YC##H/AR289S&EM$6&/;%:^D^"?#FD7JW>FZ3;6]RH(615Y7(P
M<?A1IO@GPYIFH"^L-)MH+M=V)$7D9&#CZ@FCW_(4HX:\N5RVTT6_GKM]YD0>
M#/ $\QAAT'PY),,YC2VB+#'MBB/P9X >X^SKH/AQIP2/*%M$6XZ\8S6OIG@K
MP[I>HK?:?I-M;W:[BLJ#D9&#C\":+7P3X<M=4&I6^DVT=Z',@E5>0QZG]:/?
M\@<<-=VE+;31;_?L9$?@SP!)<?9TT'PXUQDCREMHBW'7C&:!X,\ ?:?L_P#8
M/ASS\X\K[-%NS],9K7M?!/ARUU0:E;Z3;1WH<R"55Y#'J?3O1_PA/AS^UO[3
M_LFV^W^;YWG;>=^<[OKFCW_(.7#7^*6W9;_?MY_@9 \&> /M/V?^P?#GGYQY
M7V:+=GZ8S0W@WP EQY$F@^&UG) $9MH@Q/TQFM?_ (0GPY_:W]I_V3;?;_-\
M[SMO._.=WUS27'@?PW<:F=0FTBU>\,@E,I7DL.<_6CW_ "!1PU]92V[+?[]O
MZL9+^#/ "7/V>30?#BSD@",VT08Y]L9I)?!OP_AG\F;0O#<<N<!&MX0WY8K8
MNO!/AR[U0ZC<Z3;27I<2&4KR6'0_I3=0\#>&M1OWO;W1[6:ZD.YY&7EC[T>_
MV0U'#75Y2VUT6_W[?U8RIO!G@""?R9]!\.1RG&$>VB#'\,4EQX-^']M+Y=QH
M7AN%^RO;PJ?R(K8U3P3X<U74&O=1TFVN+IL;I'7DXZ9I-5\$>'-6OFO-1TFV
MN+IP TCCEL# S0^?HD$8X:\>:4MM=%OY:F3<>#/ %M($N=!\.0LPR!);1*3^
M8HN?!OP_M9 ESH/AN%B,@26T2DC\16OJG@GPYJMPD^H:3;3RH@C5F7D*.@X]
M*-5\$^'-6N$GU'2;:>5$$:LRX(4=!QZ4/GUM84(X;W>:4O/1?*VID7'@SP!;
M;/M&@^'(@XRN^VB7</;(HN/!O@"VV_:=!\.1!AE=]M$N1ZC(K7U+P3X<U/[-
M]NTFVF^SQ"&+<OW$'11["C4O!/AS4Q;?;M)MIOLT0ABW+]Q!T4>PH?/TL.,<
M-[O-*7GHOE;4R)_!G@"!(WGT'PY''(,HSVT0#?3(YHG\&> ($C>?0?#D<<@R
MC/;1 -],CFM>^\$^'+^WM(+O2;:6&T3RX%*_ZM?047W@GPY?V]I!=Z3;2PVB
M>7 I7_5KZ"G[_D*,<-IS2EYZ+;I;4R)/!G@"*&.:30?#B0O]V1K:(*WT..:)
M/!G@"*&.:30?#B0O]V1K:(*WT..:U[KP3X<NM/M;&XTFV>TM=WD1E>(]QR<?
M4T77@GPY=:?:V-QI-L]I:[O(C*\1[CDX^II>_P"0*.&TNY;ZZ+;[]S(?P9X
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M<#<88GR/J'6ME2J<GM)6L83J8>_LX-N7HK6];[_+YGH]% HJ"0HHHH ****
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MK*;)[>02(V-/LP<,"0<$$?45UWV6#_GC%_WP*YGP4JIXA\=*@"J-9CP ,?\
M,/LZP.@ZRBBB@ HHHH **** "O/_ (L?\A+X?_\ 8S0?^D]Q7H%>?_%C_D)?
M#_\ [&:#_P!)[B@#T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]3OI;R_TBVFN93EY#D%CC'.*B\^G]?@:16'NN:4MM=%O]YNW6J6-HRB[N[>
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MK3K2PN-*MGM+3=Y$>"!'N.3CZFB\OZ_X8(JAI=O?71;?>;,NIV,5NEQ)=0)
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M099V. !4&A)2-TI$D1U#(P93R".0:P?$?B2QT_2[N2*[B:XC&Q50[RLA!VY
MZ<@]?2JC%R=D3*2BKLY[4KY/%NO1Z1%;2-8VLCM<R$X&X!E7IVS@CFL:VO\
M7K*ZD@2X8V^B#$_82QAN !CKM_2N^\*Z5!8:9#+&@-Q/$KS2XPTA.6R?Q8UH
M:I81W^GW-K(,+.A1B.HR.M=/MXP?(EI_5V<OL)27.WK_ %H87BC4;>[TMK&U
MG66>XN8[1E1LE26!8'T^4-70V5K!9P)#:PQPQ+T1%"@?@*\S\-:3<:?XRT^T
MU)=TC1/<L&.[Y\L <^N *]3 J*\53M"+NMRZ$G4O.2L]A:***YSI"BBB@ HH
MHH **** "BBB@ KE/!O_ ",?CK_L,Q_^FZRKJZY3P;_R,?CK_L,Q_P#INLJ
M.KHHHH X;XB:_+8H;6VNGLVCC%Q)*%.6^;"HIQCG!)]  /XJV_$U](FEV?V2
M=H1=W,$!F0?,J.P!(R."1P#VS6Q=VL%W;O!<QK)$_#*W0UEIX>M&N=4EO$%U
M_:#J91(!@*@^10/;KGKDYH YJUN;VX\12:"^I78MH9IB+A6 E<+% P0MCL9F
M]_E'O46D:G?ZY<6-C<7\]LJZ:]TUQ#M5IG$IC#'C& %W$#CYAVKKW\.Z2]G'
M:M80^1&YD48((8]3GKDYY.>:?>:%I=[#!#<V,#QP+LB7;@(N,%1CM@#CIQ0
MSPO>S:CX8TJ]N>)[BUCE?C&6*@DXKSCXL^(476_!L+:;JY-IXBAD+K9L5EQ!
M.,1G^(_-T'8'TKUI8U2,(BA448"@8 %<#\5N-2^'^/\ H9H!_P"2]Q0!J?\
M";1?] +Q)_X*Y/\ "C_A-HO^@%XD_P#!7)_A768HQ0!R?_";1?\ 0"\2?^"N
M3_"C_A-HO^@%XD_\%<G^%=9BC% ')_\ ";1?] +Q)_X*Y/\ "C_A-HO^@%XD
M_P#!7)_A768HQ0!R?_";1?\ 0"\2?^"N3_"C_A-HO^@%XD_\%<G^%=9BC% '
M)_\ ";1?] +Q)_X*Y/\ "C_A-HO^@%XD_P#!7)_A768HQ0!R?_";1?\ 0"\2
M?^"N3_"C_A-HO^@%XD_\%<G^%=9BC% ')_\ ";1?] +Q)_X*Y/\ "C_A-HO^
M@%XD_P#!7)_A768HQ0!R?_";1?\ 0"\2?^"N3_"C_A-HO^@%XD_\%<G^%=9B
MC% ')_\ ";1?] +Q)_X*Y/\ "C_A-HO^@%XD_P#!7)_A768HQ0!R?_";1?\
M0"\2?^"N3_"C_A-HO^@%XD_\%<G^%=9BC% ')_\ ";1?] +Q)_X*Y/\ "C_A
M-HO^@%XD_P#!7)_A768HQ0!R?_";1?\ 0"\2?^"N3_"C_A-HO^@%XD_\%<G^
M%=9BC% ')_\ ";1?] +Q)_X*Y/\ "C_A-HO^@%XD_P#!7)_A768HQ0!R?_";
M1?\ 0"\2?^"N3_"C_A-HO^@%XD_\%<G^%=9BC% ')_\ ";1?] +Q)_X*Y/\
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M_42^:JHA< F-27P!]./RJ;P3IUY>:W)/K!=KC2@+>%UX4_>!'O@,*;A"EO\
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M_P! +Q)_X*Y/\*ZS%&* .3_X3:+_ * 7B3_P5R?X4?\ ";1?] +Q)_X*Y/\
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M^A-N?_!A;_\ Q5']O^)/^A-N?_!A;_\ Q5 '5T5RG]O^)/\ H3;G_P &%O\
M_%4?V_XD_P"A-N?_  86_P#\50!U=%<I_;_B3_H3;G_P86__ ,51_;_B3_H3
M;G_P86__ ,50!U=%<I_;_B3_ *$VY_\ !A;_ /Q5']O^(_\ H3KG_P &%O\
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M[S7V<Y?&_N//)Y+3P/K2K;J[0W-HS.9'Y:1,D$GU/3\:Z;0?$MGK4PBM<EQ
MLS^BDG!7ZBG>)M!@UN&$2$1RPR*ZR; 3@'E?H?\ "N;M=!7PKX@M;V"Y_P!$
MNYG@>,K@(K*649SZKUK3]W4AJ_?,OWE*>GPG4:_KD&D)$I1Y[J8[8K>+!=S]
M/3WKE]-MK[Q==_:M7CECT89>V@5P _.,-CD]"?\ /-SPG92ZGJ#^(=0.[SLB
MTA<9\I,\$'/<>U=DH Z5#DJ6D=^Y:BZWO2V['G!TJ\@UZ#P_.6_L.XEDFCC0
MX(0 MM)]-Q''^-=+XH\-1ZUI-M90R"U6!PR$)N  4C&,CV_*NB(S3J3KR<E)
M:-?U<I4(I.+V9SMGX6L8M%L].G4R);R";<"5W2#/)Q]>E=%116<I.3NV:Q@H
MJR"N:9Q;>,;^0YV?V>DC =\.]=+7FGQ(U*XTGQ!!/:;-\]DT#%AG"ENWO6N'
M@ZDN1=498B7)'F?0C\(Z?>>(-=3Q#=RJT,<S*$88; 7Y<8&,#=^E>GCI6?H$
M*P:)I\:9VK;Q@9Z_=%:%36J.I+R6B'0I\D?-ZA11161L%%%% !1110 4444
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M59[ZRCXBAR5W=<%R.IY_STKL:*/;36BLOD'L(]=?F1V\201)%$H6-%"JH'
MJ2BBLC8**** "BBB@ KF/B%:/=^'BD08GSHB=H^8#<!D?G73T54).,E)="9Q
M4XN+ZE32[46.G6UHK%E@C6,,1UP ,U;HHJ6[N[&E9604444#"BBB@ KSSXG:
M>MYJN@JV56>8V[L.H#%<?S->AUEZUI$6JM8M+(T9M;A+A2HZE>WT-:T*GLYJ
M1E7A[2#B:,,:PPQQH,(BA5'L*?0.@HK(U"BBB@ HHHH **** "BBB@ HHHH
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M>./^@SX;_P#!3/\ _)-'V3QQ_P!!GPW_ ."F?_Y)H ZNBN4^R>./^@SX;_\
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M3QQ_T&?#?_@IG_\ DF@#JZ*Y3[)XX_Z#/AO_ ,%,_P#\DT?9/''_ $&?#?\
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M#/AO_P %,_\ \DT?9/''_09\-_\ @IG_ /DF@#JZ*Y3[)XX_Z#/AO_P4S_\
MR31]D\<?]!GPW_X*9_\ Y)H ZNBN4^R>./\ H,^&_P#P4S__ "31]D\<?]!G
MPW_X*9__ ))H ZNBN4^R>./^@SX;_P#!3/\ _)-'V3QQ_P!!GPW_ ."F?_Y)
MH ZNBN4^R>./^@SX;_\ !3/_ /)-'V3QQ_T&?#?_ (*9_P#Y)H ZNBN4^R>.
M/^@SX;_\%,__ ,DT?9/''_09\-_^"F?_ .2: .KHKE/LGCC_ *#/AO\ \%,_
M_P DT?9/''_09\-_^"F?_P"2: .KHKE/LGCC_H,^&_\ P4S_ /R31]D\<?\
M09\-_P#@IG_^2: .KHKE/LGCC_H,^&__  4S_P#R31]D\<?]!GPW_P""F?\
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M@ HHHH *Y3P;_P C'XZ_[#,?_INLJZNN4\&_\C'XZ_[#,?\ Z;K*@#JZ***
M"BBB@ HHK/U+6M-TR1$O[V&!V&X*[<A?[Q]%]SQ0!H5Y_P#%C_D)?#__ +&:
M#_TGN*[\$%<@\>M>?_%8@ZE\/\<_\5-!_P"D]Q0!Z#1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_!39?_&Z] HH \__ .$0\9_]%+U+_P %-E_\;H_X1#QG_P!%+U+_ ,%-E_\
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M;B05=L],-SU.*L1QI>-#;7LZ:QIVJ1XMKT!$F5T!<*2@ _O,K  J0<\XK?\
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M-(V,<#$GR_[>W>.W3U!>E8WAFPOK6Q0ZO=M<W0X7< ?+7H!N &YL=6[FMJ@
MHHHH *K:E>PZ=937=TQ6&%2[D L<>P')/M3-4U.RTN 3:C=06L).T/-($!/I
MDUR!N[^^N-1,%]'->6<[.=(F2,1O K9C96QNRRA6#Y*ACC'% #O$%@^MW/VN
MTMH=0M+FT1;.Z$X46<F6)E!SD9#+RO/R8KH?"5U-=Z%!)<N)I%+Q><!@3!'9
M1(/9@ WXUEZ1IS7%\M]I\I@T*\A6Y:U(#"61P2>"/D!!!8#J?3G=U4:!%"J
M% P !@"@!U%%% !2,<4,P5220 .I-<?JFN1:A>6,>FZTEO8S&2)KNU,<F)QM
MV1L6#!006/3)P #Z@#O$&K0:Q:W&FV"RS3APX1HV2.[6*13+$CD;3D J>W/<
M9J'PG<V2Z^T&@R?\2^:!I)K+;M-C,I P4_@W[C\O'*Y'4TR1-7N)+6RMX[-=
M2TJ[#M*!MB:&2&51*%'?+9*=RO7!!KLK.%H;:*.25YG1 ID?&YSZG  R?84
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MD+!GBDBF<,J C#'.X!CQ@YP>E=G!#'"FV)%1<DX48&3U- $E%%% !1161?\
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M<_>XXP,G4\)V4MNL36EQ;W&CB+9:R-$1.$S\J%NZCG!ZD$>F3T] #8T$:A5
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M;11PPH,+'&H55'H .E3444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
E44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 24, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 24, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$1,085,000.00</span>. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 1,085,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-25-039436-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-039436-xbrl.zip
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M(8UF4.4&T@Y= ?E&4^^0P %_&TB-5MN576<0@@+\ 2V)$RXW4I8A=?9ZDCT
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M"15IIK_R4S[W<W[:"F>8OQ:MO2WZ^P7#P W@ (F[DXQ4&+:ZKLO:I5XNEM_
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M              "  0    !E>&9I;&EN9V9E97,N:'1M4$L%!@     !  $
*/@   ( (      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-10-24</startDate>
            <endDate>2025-10-24</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is &lt;span style="text-decoration-thickness: initial; float: none; display: inline !important;"&gt;$1,085,000.00&lt;/span&gt;. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">1085000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
